| ☑ | ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | ||||
☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | ||||
Ireland | 98-1448883 | |||||||
| (State or other jurisdiction of incorporation) | (I.R.S. Employer Identification No.) | |||||||
| 10 Riverview Drive, | Forge | |||||||
Danbury, Connecticut | 43 Church Street West | |||||||
United States 06810 | Woking, Surrey GU21 6HT | |||||||
| United Kingdom | ||||||||
| (Address of principal executive offices) (Zip Code) | ||||||||
(203) 837 - 2000 | +44 14 83 242200 | |||||||
| (Registrant's telephone number, including area code) | ||||||||
| Title of each class: | Trading Symbol(s) | Name of each exchange on which registered: | ||||||
| Ordinary shares (€0.001 nominal value per share) | LIN | NASDAQ | ||||||
| Page | ||||||||
| Part I | ||||||||
| Item 1: | ||||||||
| Item 1A: | ||||||||
| Item 1B: | ||||||||
| Item 1C: | ||||||||
| Item 2: | ||||||||
| Item 3: | ||||||||
| Item 4: | ||||||||
| Part II | ||||||||
| Item 5: | ||||||||
| Item 6: | ||||||||
| Item 7: | ||||||||
| Item 7A: | ||||||||
| Item 8: | ||||||||
| Item 9: | ||||||||
| Item 9A: | ||||||||
| Item 9B: | ||||||||
| Item 9C: | ||||||||
| Part III | ||||||||
| Item 10: | ||||||||
| Item 11: | ||||||||
| Item 12: | ||||||||
| Item 13: | ||||||||
| Item 14: | ||||||||
| Part IV | ||||||||
| Item 15: | ||||||||
| Item 16: | ||||||||
| Period | Total Number of Shares Purchased (Thousands) | Average Price Paid Per Share | Total Number of Shares Purchased as Part of Publicly Announced Programs (1) (Thousands) | Approximate Dollar Value of Shares that May Yet be Purchased Under the Programs (2) (Millions) | ||||||||||||||||||||||
| October 2025 | 872 | $ | 449.30 | 872 | $ | 8,310 | ||||||||||||||||||||
| November 2025 | 1,045 | $ | 416.69 | 1,045 | $ | 7,874 | ||||||||||||||||||||
| December 2025 | 1,390 | $ | 412.33 | 1,390 | $ | 7,301 | ||||||||||||||||||||
| Fourth Quarter 2025 | 3,307 | $ | 423.46 | 3,307 | $ | 7,301 | ||||||||||||||||||||

| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |||||||||||||||
| LIN | $100 | $133 | $128 | $163 | $168 | $173 | ||||||||||||||
| SPX | $100 | $129 | $105 | $133 | $166 | $196 | ||||||||||||||
| S5MATR | $100 | $127 | $112 | $126 | $126 | $139 | ||||||||||||||
| Page | |||||
| North and South America ("Americas") | Europe, Middle East and Africa (“EMEA”) | Asia and Pacific (“APAC”) | ||||||||||||
| United States | Germany | China | ||||||||||||
| Brazil | United Kingdom | Australia | ||||||||||||
| Mexico | Eastern Europe | South Korea | ||||||||||||
| Canada | India | |||||||||||||
(Millions of dollars, except per share data) Year Ended December 31, | 2025 | 2024 | Variance | ||||||||||||||
| Reported Amounts | |||||||||||||||||
| Sales | $ | 33,986 | $ | 33,005 | 3 | % | |||||||||||
| Cost of sales, exclusive of depreciation and amortization | $ | 17,389 | $ | 17,143 | 1 | % | |||||||||||
| As a percent of sales | 51.2 | % | 51.9 | % | |||||||||||||
| Selling, general and administrative | $ | 3,433 | $ | 3,337 | 3 | % | |||||||||||
| As a percent of sales | 10.1 | % | 10.1 | % | |||||||||||||
| Depreciation and amortization | $ | 3,763 | $ | 3,780 | — | % | |||||||||||
| Cost reduction program and other charges (a) | $ | 273 | $ | 145 | 88 | % | |||||||||||
| Other income (expense) - net | $ | (58) | $ | 185 | (131) | % | |||||||||||
| Operating profit | $ | 8,923 | $ | 8,635 | 3 | % | |||||||||||
| Operating margin | 26.3 | % | 26.2 | % | |||||||||||||
| Interest expense - net | $ | 255 | $ | 256 | — | % | |||||||||||
| Net pension and OPEB cost (benefit), excluding service cost | $ | (229) | $ | (190) | 21 | % | |||||||||||
| Effective tax rate | 22.4 | % | 23.4 | % | |||||||||||||
| Income from equity investments | $ | 150 | $ | 170 | (12) | % | |||||||||||
| Noncontrolling interests | $ | (160) | $ | (172) | (7) | % | |||||||||||
| Net Income – Linde plc | $ | 6,898 | $ | 6,565 | 5 | % | |||||||||||
| Diluted earnings per share | $ | 14.61 | $ | 13.62 | 7 | % | |||||||||||
| Diluted shares outstanding | 472,195 | 482,092 | (2) | % | |||||||||||||
| Number of employees | 65,177 | 65,289 | — | % | |||||||||||||
| Adjusted Amounts (b) | |||||||||||||||||
| Depreciation and amortization | $ | 2,986 | $ | 2,857 | 5 | % | |||||||||||
| Operating profit | $ | 10,137 | $ | 9,720 | 4 | % | |||||||||||
| Operating margin | 29.8 | % | 29.5 | % | |||||||||||||
| Net Income – Linde plc | $ | 7,772 | $ | 7,475 | 4 | % | |||||||||||
| Diluted earnings per share | $ | 16.46 | $ | 15.51 | 6 | % | |||||||||||
| Other Financial Data (b) | |||||||||||||||||
| EBITDA | $ | 12,836 | $ | 12,585 | 2 | % | |||||||||||
| As percent of sales | 37.8 | % | 38.1 | % | |||||||||||||
| Adjusted EBITDA | $ | 13,351 | $ | 12,819 | 4 | % | |||||||||||
| As percent of sales | 39.3 | % | 38.8 | % | |||||||||||||
| 2025 vs 2024 | ||||||||
| % Change | ||||||||
| Factors Contributing to Changes - Sales | ||||||||
| Volume | — | % | ||||||
| Price/Mix | 2 | % | ||||||
| Cost pass-through | — | % | ||||||
| Currency | — | % | ||||||
| Acquisitions/Divestitures | 1 | % | ||||||
| Engineering | — | % | ||||||
| 3 | % | |||||||
(Millions of dollars) Year Ended December 31, | 2025 | 2024 | Variance | ||||||||||||||
| Sales | |||||||||||||||||
| Americas | $ | 15,208 | $ | 14,442 | 5 | % | |||||||||||
| EMEA | 8,549 | 8,352 | 2 | % | |||||||||||||
| APAC | 6,661 | 6,632 | — | % | |||||||||||||
| Engineering | 2,250 | 2,322 | (3) | % | |||||||||||||
| Other | 1,318 | 1,257 | 5 | % | |||||||||||||
| Total sales | $ | 33,986 | $ | 33,005 | 3 | % | |||||||||||
| Operating Profit | |||||||||||||||||
| Americas | $ | 4,747 | $ | 4,550 | 4 | % | |||||||||||
| EMEA | 3,055 | 2,780 | 10 | % | |||||||||||||
| APAC | 1,933 | 1,918 | 1 | % | |||||||||||||
| Engineering | 408 | 410 | (1) | % | |||||||||||||
| Other | (6) | 62 | (110) | % | |||||||||||||
| Segment operating profit | 10,137 | 9,720 | 4 | % | |||||||||||||
| Reconciliation to reported operating profit: | |||||||||||||||||
Cost reduction program and other charges (Note 3) | (273) | (145) | |||||||||||||||
| Purchase accounting impacts - Linde AG | (941) | (940) | |||||||||||||||
| Total operating profit | $ | 8,923 | $ | 8,635 | |||||||||||||
| (Dollar amounts in millions) | Variance | |||||||||||||||||||
Year Ended December 31, | 2025 | 2024 | 2025 vs 2024 | |||||||||||||||||
| Sales | $ | 15,208 | $ | 14,442 | 5 | % | ||||||||||||||
| Operating profit | $ | 4,747 | $ | 4,550 | 4 | % | ||||||||||||||
| As a percent of sales | 31.2 | % | 31.5 | % | ||||||||||||||||
| 2025 vs 2024 | ||||||||
| % Change | ||||||||
Factors Contributing to Changes - Sales | ||||||||
| Volume | 1 | % | ||||||
| Price/Mix | 3 | % | ||||||
| Cost pass-through | 1 | % | ||||||
| Currency | (1) | % | ||||||
| Acquisitions/Divestitures | 1 | % | ||||||
| 5 | % | |||||||
| (Dollar amounts in millions) | Variance | |||||||||||||||||||
| Year Ended December 31, | 2025 | 2024 | 2025 vs 2024 | |||||||||||||||||
| Sales | $ | 8,549 | $ | 8,352 | 2 | % | ||||||||||||||
| Operating profit | $ | 3,055 | $ | 2,780 | 10 | % | ||||||||||||||
| As a percent of sales | 35.7 | % | 33.3 | % | ||||||||||||||||
| 2025 vs 2024 | ||||||||
| % Change | ||||||||
Factors Contributing to Changes - Sales | ||||||||
| Volume | (3) | % | ||||||
| Price/Mix | 2 | % | ||||||
| Cost pass-through | — | % | ||||||
| Currency | 3 | % | ||||||
| Acquisitions/Divestitures | — | % | ||||||
| 2 | % | |||||||
| (Dollar amounts in millions) | Variance | |||||||||||||||||||
| Year Ended December 31, | 2025 | 2024 | 2025 vs 2024 | |||||||||||||||||
| Sales | $ | 6,661 | $ | 6,632 | — | % | ||||||||||||||
| Operating profit | $ | 1,933 | $ | 1,918 | 1 | % | ||||||||||||||
| As a percent of sales | 29.0 | % | 28.9 | % | ||||||||||||||||
| 2025 vs 2024 | ||||||||
| % Change | ||||||||
Factors Contributing to Changes - Sales | ||||||||
| Volume | (1) | % | ||||||
| Price/Mix | — | % | ||||||
| Cost pass-through | — | % | ||||||
| Currency | (1) | % | ||||||
| Acquisitions/Divestitures | 2 | % | ||||||
| — | % | |||||||
| (Dollar amounts in millions) | Variance | |||||||||||||||||||
| Year Ended December 31, | 2025 | 2024 | 2025 vs 2024 | |||||||||||||||||
| Sales | $ | 2,250 | $ | 2,322 | (3) | % | ||||||||||||||
| Operating profit | $ | 408 | 410 | (1) | % | |||||||||||||||
| As a percent of sales | 18.1 | % | 17.7 | % | ||||||||||||||||
| (Dollar amounts in millions) | Variance | |||||||||||||||||||
| Year Ended December 31, | 2025 | 2024 | 2025 vs 2024 | |||||||||||||||||
| Sales | $ | 1,318 | $ | 1,257 | 5 | % | ||||||||||||||
| Operating profit | $ | (6) | $ | 62 | (110) | % | ||||||||||||||
| As a percent of sales | (0.5) | % | 4.9 | % | ||||||||||||||||
| 2025 vs 2024 | ||||||||
| % Change | ||||||||
Factors Contributing to Changes - Sales | ||||||||
| Volume/Price | 4 | % | ||||||
| Currency | 1 | % | ||||||
| Acquisitions/Divestitures | — | % | ||||||
| 5 | % | |||||||
Percentage of 2025 Consolidated Sales | Exchange Rate for Statements of Income | Exchange Rate for Balance Sheet | |||||||||||||||||||||||||||
| Average Year Ended December 31, | December 31, | ||||||||||||||||||||||||||||
| Currency | 2025 | 2024 | 2025 | 2024 | |||||||||||||||||||||||||
| Euro | 17 | % | 0.89 | 0.92 | 0.85 | 0.97 | |||||||||||||||||||||||
| Chinese yuan | 7 | % | 7.19 | 7.20 | 6.99 | 7.30 | |||||||||||||||||||||||
| British pound | 4 | % | 0.76 | 0.78 | 0.74 | 0.80 | |||||||||||||||||||||||
| Brazilian real | 4 | % | 5.59 | 5.37 | 5.47 | 6.18 | |||||||||||||||||||||||
| Australian dollar | 4 | % | 1.55 | 1.52 | 1.50 | 1.62 | |||||||||||||||||||||||
| Mexican peso | 3 | % | 19.17 | 18.22 | 18.01 | 20.83 | |||||||||||||||||||||||
| Korean won | 3 | % | 1,421 | 1,363 | 1,440 | 1,472 | |||||||||||||||||||||||
| Canadian dollar | 3 | % | 1.40 | 1.37 | 1.37 | 1.44 | |||||||||||||||||||||||
| Indian rupee | 2 | % | 87.13 | 83.67 | 89.88 | 85.61 | |||||||||||||||||||||||
| Swedish krona | 1 | % | 9.79 | 10.57 | 9.21 | 11.07 | |||||||||||||||||||||||
| South African rand | 1 | % | 17.87 | 18.32 | 16.56 | 18.84 | |||||||||||||||||||||||
| Swiss franc | 1 | % | 0.83 | 0.88 | 0.79 | 0.91 | |||||||||||||||||||||||
(Millions of dollars) Year Ended December 31, | 2025 | 2024 | |||||||||
| Net Cash Provided by (Used for) | |||||||||||
| Operating Activities | |||||||||||
| Net income (including noncontrolling interests) | $ | 7,058 | $ | 6,737 | |||||||
| Non-cash charges (credits): | |||||||||||
| Add: Cost reduction program and other charges, net of payments (a) | 139 | 31 | |||||||||
| Add: Depreciation and amortization | 3,763 | 3,780 | |||||||||
| Add (Less): Deferred income taxes | (465) | (142) | |||||||||
| Add (Less): Non-cash charges and other | 187 | 88 | |||||||||
| Net income adjusted for non-cash charges and other | 10,682 | 10,494 | |||||||||
| Less: Pension contributions | (25) | (35) | |||||||||
| Add (Less): Working capital | (240) | (845) | |||||||||
| Add (Less): Other | (67) | (191) | |||||||||
| Net cash provided by (used for) operating activities | $ | 10,350 | $ | 9,423 | |||||||
| Investing Activities | |||||||||||
| Capital expenditures | $ | (5,261) | $ | (4,497) | |||||||
| Acquisitions, net of cash acquired | (412) | (317) | |||||||||
| Divestitures, net of cash divested and asset sales | 42 | 170 | |||||||||
| Other investing, net | (90) | — | |||||||||
| Net cash provided by (used for) investing activities | $ | (5,721) | $ | (4,644) | |||||||
| Financing Activities | |||||||||||
| Debt increases (decreases) – net | $ | 2,911 | $ | 3,167 | |||||||
| Issuances (purchases) of ordinary shares – net | (4,578) | (4,451) | |||||||||
| Cash dividends – Linde plc shareholders | (2,811) | (2,655) | |||||||||
| Noncontrolling interest transactions and other | (76) | (420) | |||||||||
| Net cash provided by (used for) financing activities | $ | (4,554) | $ | (4,359) | |||||||
| Effect of exchange rate changes on cash | $ | 131 | $ | (234) | |||||||
| Cash and cash equivalents, end-of-period | $ | 5,056 | $ | 4,850 | |||||||
| (Dollar amounts in millions, except per share data) | ||||||||
| Year Ended December 31, | 2025 | 2024 | ||||||
| Adjusted Operating Profit and Operating Margin | ||||||||
| Reported operating profit | $ | 8,923 | $ | 8,635 | ||||
| Add: Cost reduction program and other charges | 273 | 145 | ||||||
| Add: Purchase accounting impacts - Linde AG (c) | 941 | 940 | ||||||
| Total adjustments | 1,214 | 1,085 | ||||||
| Adjusted operating profit | $ | 10,137 | $ | 9,720 | ||||
| Reported percentage change | 3 | % | ||||||
| Adjusted percentage change | 4 | % | ||||||
| Reported sales | $ | 33,986 | $ | 33,005 | ||||
| Reported operating margin | 26.3 | % | 26.2 | % | ||||
| Adjusted operating margin | 29.8 | % | 29.5 | % | ||||
| Adjusted Depreciation and Amortization | ||||||||
| Reported depreciation and amortization | $ | 3,763 | $ | 3,780 | ||||
| Less: Purchase accounting impacts - Linde AG (c) | (777) | (923) | ||||||
| Adjusted depreciation and amortization | $ | 2,986 | $ | 2,857 | ||||
| Adjusted Other Income (Expense) - net | ||||||||
| Reported other income (expense) - net | $ | (58) | $ | 185 | ||||
| Add: Purchase accounting impacts - Linde AG (c) (d) | (164) | (17) | ||||||
| Adjusted other income (expense) - net | $ | 106 | $ | 202 | ||||
| Adjusted Net Pension and OPEB Cost (Benefit), Excluding Service Cost | ||||||||
| Reported net pension and OPEB cost (benefit), excluding service cost | $ | (229) | $ | (190) | ||||
| Add: Pension settlement charges | (2) | (10) | ||||||
| Adjusted Net Pension and OPEB cost (benefit), excluding service costs | $ | (231) | $ | (200) | ||||
| Adjusted Interest Expense - Net | ||||||||
| Reported interest expense - net | $ | 255 | $ | 256 | ||||
| Add: Purchase accounting impacts - Linde AG (c) | — | 3 | ||||||
| Adjusted interest expense - net | $ | 255 | $ | 259 | ||||
| (Millions of dollars) | |||||||||||
December 31, | 2025 | 2024 | |||||||||
| Debt | $ | 26,989 | $ | 21,623 | |||||||
| Less: cash and cash equivalents | (5,056) | (4,850) | |||||||||
| Net debt | 21,933 | 16,773 | |||||||||
| Less: purchase accounting impacts - Linde AG | (3) | (4) | |||||||||
| Adjusted net debt | $ | 21,930 | $ | 16,769 | |||||||
| (Millions of dollars) | |||||||||||
| Statement of Income Data | |||||||||||
| Year Ended December 31, | 2025 | 2024 | |||||||||
| Sales | $ | 8,844 | $ | 7,995 | |||||||
| Operating profit | 1,512 | 1,526 | |||||||||
| Net income | 3 | 3,553 | |||||||||
| Transactions with non-guarantor subsidiaries | 3,989 | 7,177 | |||||||||
| Balance Sheet Data (at period end) | |||||||||||
| Current assets (a) | 4,815 | 7,827 | |||||||||
| Long-term assets (b) | 16,808 | 14,481 | |||||||||
| Current liabilities (c) | 10,085 | 10,309 | |||||||||
| Long-term liabilities (d) | 73,336 | 64,848 | |||||||||
(a) From current assets above, amount due from non-guarantor subsidiaries | 1,097 | 4,425 | |||||||||
| (b) From long-term assets above, amount due from non-guarantor subsidiaries | 724 | 1,031 | |||||||||
| (c) From current liabilities above, amount due to non-guarantor subsidiaries | 1,325 | 1,841 | |||||||||
| (d) From long-term liabilities above, amount due to non-guarantor subsidiaries | $ | 48,301 | $ | 45,378 | |||||||
| Page | |||||
| Audited Consolidated Financial Statements | |||||
| Notes to Consolidated Financial Statements | |||||
/s/ SANJIV LAMBA | /s/ KELCEY E. HOYT | |||||||
Sanjiv Lamba Chairman and Chief Executive Officer | Kelcey E. Hoyt Chief Accounting Officer | |||||||
/s/ MATTHEW J. WHITE | ||||||||
| Matthew J. White Chief Financial Officer | February 25, 2026 | |||||||
| Year Ended December 31, | 2025 | 2024 | 2023 | ||||||||||||||
| Sales | $ | 33,986 | $ | 33,005 | $ | 32,854 | |||||||||||
| Cost of sales, exclusive of depreciation and amortization | 17,389 | 17,143 | 17,492 | ||||||||||||||
| Selling, general and administrative | 3,433 | 3,337 | 3,295 | ||||||||||||||
| Depreciation and amortization | 3,763 | 3,780 | 3,816 | ||||||||||||||
| Research and development | 147 | 150 | 146 | ||||||||||||||
| Cost reduction program and other charges | 273 | 145 | 40 | ||||||||||||||
| Other income (expense) - net | (58) | 185 | (41) | ||||||||||||||
| Operating Profit | 8,923 | 8,635 | 8,024 | ||||||||||||||
| Interest expense - net | 255 | 256 | 200 | ||||||||||||||
| Net pension and OPEB cost (benefit), excluding service cost | (229) | (190) | (164) | ||||||||||||||
| Income Before Income Taxes and Equity Investments | 8,897 | 8,569 | 7,988 | ||||||||||||||
| Income taxes | 1,989 | 2,002 | 1,814 | ||||||||||||||
| Income Before Equity Investments | 6,908 | 6,567 | 6,174 | ||||||||||||||
| Income from equity investments | 150 | 170 | 167 | ||||||||||||||
| Net Income (Including Noncontrolling Interests) | 7,058 | 6,737 | 6,341 | ||||||||||||||
| Less: noncontrolling interests | (160) | (172) | (142) | ||||||||||||||
| Net Income – Linde plc | $ | 6,898 | $ | 6,565 | $ | 6,199 | |||||||||||
| Per Share Data – Linde plc Shareholders | |||||||||||||||||
| Basic earnings per share | $ | 14.69 | $ | 13.71 | $ | 12.70 | |||||||||||
| Diluted earnings per share | $ | 14.61 | $ | 13.62 | $ | 12.59 | |||||||||||
| Weighted Average Shares Outstanding (000’s): | |||||||||||||||||
| Basic shares outstanding | 469,488 | 478,773 | 488,191 | ||||||||||||||
| Diluted shares outstanding | 472,195 | 482,092 | 492,290 | ||||||||||||||
| Year Ended December 31, | 2025 | 2024 | 2023 | ||||||||||||||
| NET INCOME (INCLUDING NONCONTROLLING INTERESTS) | $ | 7,058 | $ | 6,737 | $ | 6,341 | |||||||||||
| OTHER COMPREHENSIVE INCOME (LOSS) | |||||||||||||||||
| Translation adjustments: | |||||||||||||||||
| Foreign currency translation adjustments | 714 | (1,638) | 399 | ||||||||||||||
| Reclassifications to net income | (80) | — | — | ||||||||||||||
| Income taxes | 12 | 6 | 1 | ||||||||||||||
| Translation adjustments | 646 | (1,632) | 400 | ||||||||||||||
| Funded status - retirement obligations (Note 16): | |||||||||||||||||
| Retirement program remeasurements | 60 | 674 | (480) | ||||||||||||||
| Reclassifications to net income | (28) | — | (14) | ||||||||||||||
| Income taxes | (7) | (155) | 114 | ||||||||||||||
| Funded status - retirement obligations | 25 | 519 | (380) | ||||||||||||||
| Derivative instruments (Note 12): | |||||||||||||||||
| Current year unrealized gain (loss) | 53 | (38) | (80) | ||||||||||||||
| Reclassifications to net income | (23) | 22 | 13 | ||||||||||||||
| Income taxes | (8) | 3 | 12 | ||||||||||||||
| Derivative instruments | 22 | (13) | (55) | ||||||||||||||
| TOTAL OTHER COMPREHENSIVE INCOME (LOSS) | 693 | (1,126) | (35) | ||||||||||||||
| COMPREHENSIVE INCOME (INCLUDING NONCONTROLLING INTERESTS) | 7,751 | 5,611 | 6,306 | ||||||||||||||
| Less: noncontrolling interests | (192) | (135) | (130) | ||||||||||||||
| COMPREHENSIVE INCOME - LINDE PLC | $ | 7,559 | $ | 5,476 | $ | 6,176 | |||||||||||
| December 31, | 2025 | 2024 | |||||||||
| Assets | |||||||||||
| Cash and cash equivalents | $ | 5,056 | $ | 4,850 | |||||||
| Accounts receivable - net | 4,966 | 4,622 | |||||||||
| Contract assets | 269 | 263 | |||||||||
| Inventories | 2,055 | 1,946 | |||||||||
| Prepaid and other current assets | 979 | 1,264 | |||||||||
| Total Current Assets | 13,325 | 12,945 | |||||||||
| Property, plant and equipment - net | 28,260 | 24,775 | |||||||||
| Equity investments | 2,015 | 2,130 | |||||||||
| Goodwill | 27,927 | 25,937 | |||||||||
| Other intangible assets – net | 11,871 | 11,330 | |||||||||
| Other long-term assets | 3,419 | 3,030 | |||||||||
| Total Assets | $ | 86,817 | $ | 80,147 | |||||||
| Liabilities and Equity | |||||||||||
| Accounts payable | $ | 2,810 | $ | 2,507 | |||||||
| Short-term debt | 4,510 | 4,223 | |||||||||
| Current portion of long-term debt | 1,796 | 2,057 | |||||||||
| Contract liabilities | 1,231 | 1,194 | |||||||||
| Accrued taxes | 680 | 637 | |||||||||
| Other current liabilities | 4,171 | 3,926 | |||||||||
| Total Current Liabilities | 15,198 | 14,544 | |||||||||
| Long-term debt | 20,683 | 15,343 | |||||||||
| Other long-term liabilities | 4,355 | 4,015 | |||||||||
| Deferred credits | 6,840 | 6,757 | |||||||||
| Total Liabilities | 47,076 | 40,659 | |||||||||
| Commitments and contingencies (Note 17) | |||||||||||
| Redeemable noncontrolling interests | 13 | 13 | |||||||||
| Linde plc Shareholders’ Equity: | |||||||||||
Ordinary shares, €0.001 par value, authorized 1,750,000,000 shares, 2025 and 2024 issued: 490,766,972 ordinary shares | 1 | 1 | |||||||||
| Additional paid-in capital | 39,430 | 39,603 | |||||||||
| Retained earnings | 16,608 | 12,634 | |||||||||
| Accumulated other comprehensive income (loss) | (6,233) | (6,894) | |||||||||
Less: Treasury shares, at cost (2025 – 27,086,030 shares and 2024 – 17,530,240 shares) | (11,561) | (7,252) | |||||||||
| Total Linde plc Shareholders’ Equity | 38,245 | 38,092 | |||||||||
| Noncontrolling interests | 1,483 | 1,383 | |||||||||
| Total Equity | 39,728 | 39,475 | |||||||||
| Total Liabilities and Equity | $ | 86,817 | $ | 80,147 | |||||||
| Year Ended December 31, | 2025 | 2024 | 2023 | ||||||||||||||
| Increase (Decrease) in Cash and Cash Equivalents | |||||||||||||||||
| Operations | |||||||||||||||||
| Net income – Linde plc | $ | 6,898 | $ | 6,565 | $ | 6,199 | |||||||||||
| Add: Noncontrolling interests | 160 | 172 | 142 | ||||||||||||||
| Net Income (including noncontrolling interests) | $ | 7,058 | $ | 6,737 | $ | 6,341 | |||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||||||||||||||
| Cost reduction program and other charges | 139 | 31 | (118) | ||||||||||||||
| Depreciation and amortization | 3,763 | 3,780 | 3,816 | ||||||||||||||
| Deferred income taxes | (465) | (142) | (84) | ||||||||||||||
| Share-based compensation | 164 | 160 | 141 | ||||||||||||||
| Non-cash charges and other | 23 | (72) | 43 | ||||||||||||||
| Working capital | |||||||||||||||||
| Accounts receivable | (122) | (160) | (86) | ||||||||||||||
| Contract assets and liabilities, net | (72) | (409) | (168) | ||||||||||||||
| Inventory | 47 | 56 | (127) | ||||||||||||||
| Prepaid and other current assets | 55 | (55) | 66 | ||||||||||||||
| Payables and accruals | (148) | (277) | (168) | ||||||||||||||
| Pension contributions | (25) | (35) | (46) | ||||||||||||||
| Long-term assets, liabilities and other | (67) | (191) | (305) | ||||||||||||||
| Net cash provided by operating activities | 10,350 | 9,423 | 9,305 | ||||||||||||||
| Investing | |||||||||||||||||
| Capital expenditures | (5,261) | (4,497) | (3,787) | ||||||||||||||
| Acquisitions, net of cash acquired | (412) | (317) | (953) | ||||||||||||||
| Divestitures, net of cash divested and asset sales | 42 | 170 | 70 | ||||||||||||||
| Other investing, net | (90) | — | — | ||||||||||||||
| Net cash used for investing activities | (5,721) | (4,644) | (4,670) | ||||||||||||||
| Financing | |||||||||||||||||
| Short-term debt borrowings (repayments) – net | 41 | (372) | 554 | ||||||||||||||
| Long-term debt borrowings | 5,148 | 4,844 | 2,188 | ||||||||||||||
| Long-term debt repayments | (2,278) | (1,305) | (1,682) | ||||||||||||||
| Issuances of ordinary shares | 23 | 31 | 33 | ||||||||||||||
| Purchases of ordinary shares | (4,601) | (4,482) | (3,958) | ||||||||||||||
| Cash dividends - Linde plc shareholders | (2,811) | (2,655) | (2,482) | ||||||||||||||
| Noncontrolling interest transactions and other | (76) | (420) | (53) | ||||||||||||||
| Net cash used for financing activities | (4,554) | (4,359) | (5,400) | ||||||||||||||
| Effect of exchange rate changes on cash and cash equivalents | 131 | (234) | (7) | ||||||||||||||
| Change in cash and cash equivalents | 206 | 186 | (772) | ||||||||||||||
| Cash and cash equivalents, beginning-of-period | 4,850 | 4,664 | 5,436 | ||||||||||||||
| Cash and cash equivalents, end-of-period | $ | 5,056 | $ | 4,850 | $ | 4,664 | |||||||||||
| Supplemental Data | |||||||||||||||||
| Interest paid, net of capitalized interest | $ | 548 | $ | 443 | $ | 451 | |||||||||||
| Linde plc Shareholders’ Equity | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Ordinary shares | Additional Paid-in Capital | Retained Earnings | Accumulated Other Comprehensive Income (Loss) (Note 7) | Treasury Stock | Linde plc Shareholders’ Equity | Noncontrolling Interests | Total Equity | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Activity | Shares | Amounts | Shares | Amounts | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Balance, December 31, 2022 | 552,013 | $ | 1 | $ | 40,005 | $ | 20,541 | $ | (5,782) | 59,555 | $ | (14,737) | $ | 40,028 | $ | 1,346 | $ | 41,374 | |||||||||||||||||||||||||||||||||||||||||
| Net Income available for Linde plc shareholders | 6,199 | 6,199 | 142 | 6,341 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Other comprehensive income (loss) | (23) | (23) | (12) | (35) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Noncontrolling interests: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Dividends and other capital reductions | — | (113) | (113) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Additions (Reductions) | $ | (12) | (12) | (1) | (13) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Dividends ($5.10 per ordinary share) | (2,482) | (2,482) | (2,482) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Issuances of ordinary shares: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| For employee savings and incentive plans | (322) | (113) | (924) | 307 | (128) | (128) | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Purchases of ordinary shares | 10,937 | (4,003) | (4,003) | (4,003) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Share-based compensation | 141 | 141 | 141 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Intercompany reorganization (Note 14) | (61,246) | (15,300) | (61,246) | 15,300 | — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Balance, December 31, 2023 | 490,767 | $ | 1 | $ | 39,812 | $ | 8,845 | $ | (5,805) | 8,322 | $ | (3,133) | $ | 39,720 | $ | 1,362 | $ | 41,082 | |||||||||||||||||||||||||||||||||||||||||
| Net Income available for Linde plc shareholders | 6,565 | 6,565 | 172 | 6,737 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Other comprehensive income (loss) | (1,089) | (1,089) | (37) | (1,126) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Noncontrolling interests: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Dividends and other capital reductions | — | (133) | (133) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Additions (Reductions) | — | 19 | 19 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Dividends ($5.56 per ordinary share) | (2,655) | (2,655) | (2,655) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Issuances of ordinary shares: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| For employee savings and incentive plans | (369) | (121) | (868) | 340 | (150) | (150) | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Purchases of ordinary shares | 10,076 | (4,459) | (4,459) | (4,459) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Share-based compensation | 160 | 160 | 160 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Balance, December 31, 2024 | 490,767 | $ | 1 | $ | 39,603 | $ | 12,634 | $ | (6,894) | 17,530 | $ | (7,252) | $ | 38,092 | $ | 1,383 | $ | 39,475 | |||||||||||||||||||||||||||||||||||||||||
| Net Income available for Linde plc shareholders | 6,898 | 6,898 | 160 | 7,058 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Other comprehensive income (loss) | 661 | 661 | 32 | 693 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Noncontrolling interests: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Dividends and other capital reductions | — | (119) | (119) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Additions (Reductions) | (4) | (4) | 27 | 23 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Dividends ($6.00 per ordinary share) | (2,811) | (2,811) | (2,811) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Issuances of ordinary shares: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| For employee savings and incentive plans | (333) | (113) | (706) | 297 | (149) | (149) | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Purchases of ordinary shares | 10,262 | (4,606) | (4,606) | (4,606) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Share-based compensation | 164 | 164 | 164 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Balance, December 31, 2025 | 490,767 | $ | 1 | $ | 39,430 | $ | 16,608 | $ | (6,233) | 27,086 | $ | (11,561) | $ | 38,245 | $ | 1,483 | $ | 39,728 | |||||||||||||||||||||||||||||||||||||||||
| (Millions of dollars) | January 5, 2023 | ||||
| Assets: | |||||
| Cash and cash equivalents | $ | 55 | |||
| Other current assets - net | 49 | ||||
| Property, plant and equipment, net | 241 | ||||
| Other intangible assets - net | 245 | ||||
| Other long-term liabilities - net | (1) | ||||
| Deferred taxes | (25) | ||||
| Total identifiable net assets | $ | 564 | |||
| Goodwill | $ | 485 | |||
| Fair value of previously held equity interest | $ | 183 | |||
| Total purchase price | $ | 866 | |||
| (millions of dollars) | Severance costs | Other charges | Total | |||||||||||||||||
| Balance, December 31, 2023 | $ | 172 | $ | 42 | $ | 214 | ||||||||||||||
| 2024 Cost reduction program and other charges | 165 | (20) | 145 | |||||||||||||||||
| Less: Cash payments, net | (133) | 19 | (114) | |||||||||||||||||
| Less: Non-cash charges | — | 4 | 4 | |||||||||||||||||
| Foreign currency translation and other | (8) | — | (8) | |||||||||||||||||
| Balance, December 31, 2024 | $ | 196 | $ | 45 | $ | 241 | ||||||||||||||
| 2025 Cost reduction program and other charges | 308 | (35) | 273 | |||||||||||||||||
| Less: Cash payments, net | (136) | 2 | (134) | |||||||||||||||||
| Less: Non-cash charges | — | 40 | 40 | |||||||||||||||||
| Foreign currency translation and other | 17 | 1 | 18 | |||||||||||||||||
| Balance, December 31, 2025 | $ | 385 | $ | 53 | $ | 438 | ||||||||||||||
| (Millions of dollars) | |||||||||||
| December 31, | 2025 | 2024 | |||||||||
| Operating Leases | |||||||||||
| $ | 886 | $ | 800 | ||||||||
| 199 | 176 | ||||||||||
| 667 | 606 | ||||||||||
| Total operating lease liabilities | 866 | 782 | |||||||||
| Finance Leases | |||||||||||
| 193 | 189 | ||||||||||
| 62 | 54 | ||||||||||
| 152 | 150 | ||||||||||
| Total finance lease liabilities | $ | 214 | $ | 204 | |||||||
| (Millions of dollars) | |||||||||||
| December 31, | 2025 | 2024 | |||||||||
| Weighted average lease term (years) | 8 | 8 | |||||||||
| Weighted average discount rate | 4.46 | % | 4.17 | % | |||||||
| Period | Operating Leases | Financing Leases | ||||||||||||
| 2026 | $ | 232 | $ | 65 | ||||||||||
| 2027 | 183 | 55 | ||||||||||||
| 2028 | 139 | 40 | ||||||||||||
| 2029 | 103 | 25 | ||||||||||||
| 2030 | 68 | 12 | ||||||||||||
| Thereafter | 322 | 44 | ||||||||||||
| Total future undiscounted lease payments | 1,047 | 241 | ||||||||||||
| Less imputed interest | (181) | (27) | ||||||||||||
| Total reported lease liability | $ | 866 | $ | 214 | ||||||||||
(Millions of dollars) Year Ended December 31, | 2025 | 2024 | 2023 | ||||||||||||||
| United States | $ | 2,934 | $ | 2,717 | $ | 2,859 | |||||||||||
| Non-U.S. | 5,963 | 5,852 | 5,129 | ||||||||||||||
| Total income before income taxes | $ | 8,897 | $ | 8,569 | $ | 7,988 | |||||||||||
(Millions of dollars) Year Ended December 31, | 2025 | 2024 | 2023 | ||||||||||||||
| Current tax expense (benefit) | |||||||||||||||||
| U.S. federal | $ | 475 | $ | 436 | $ | 260 | |||||||||||
| State and local | 114 | 106 | 116 | ||||||||||||||
| Non-U.S. | 1,865 | 1,602 | 1,522 | ||||||||||||||
| 2,454 | 2,144 | 1,898 | |||||||||||||||
| Deferred tax expense (benefit) | |||||||||||||||||
| U.S. federal | 46 | 3 | 57 | ||||||||||||||
| State and local | (15) | 11 | 5 | ||||||||||||||
| Non-U.S. | (496) | (156) | (146) | ||||||||||||||
| (465) | (142) | (84) | |||||||||||||||
| Total income taxes | $ | 1,989 | $ | 2,002 | $ | 1,814 | |||||||||||
(Dollar amounts in millions) Year Ended December 31, | 2025 | 2024 | 2023 | ||||||||||||||||||||||||||||||||
| U.S. Federal statutory income tax | $ | 1,868 | 21.0 | % | $ | 1,800 | 21.0 | % | $ | 1,677 | 21.0 | % | |||||||||||||||||||||||
| State and local income taxes, net of Federal income tax effect (a) | 88 | 1.0 | % | 102 | 1.2 | % | 105 | 1.3 | % | ||||||||||||||||||||||||||
| Foreign tax effects | |||||||||||||||||||||||||||||||||||
| Germany | |||||||||||||||||||||||||||||||||||
| Changes in tax laws or rates | (158) | (1.8) | % | — | — | % | — | — | % | ||||||||||||||||||||||||||
| Other | 60 | 0.7 | % | 49 | 0.6 | % | 60 | 0.8 | % | ||||||||||||||||||||||||||
| Other foreign jurisdictions | 201 | 2.2 | % | 172 | 2.0 | % | 148 | 1.9 | % | ||||||||||||||||||||||||||
| Share-based compensation | (60) | (0.7) | % | (63) | (0.7) | % | (63) | (0.8) | % | ||||||||||||||||||||||||||
| Tax credits | (42) | (0.5) | % | (45) | (0.5) | % | (20) | (0.3) | % | ||||||||||||||||||||||||||
| Changes in unrecognized tax benefits | 10 | 0.2 | % | 2 | — | % | (54) | (0.7) | % | ||||||||||||||||||||||||||
| Other adjustments | 22 | 0.3 | % | (15) | (0.2) | % | (39) | (0.5) | % | ||||||||||||||||||||||||||
| Provision for income taxes | $ | 1,989 | 22.4 | % | $ | 2,002 | 23.4 | % | $ | 1,814 | 22.7 | % | |||||||||||||||||||||||
| (a) In 2025, 2024, and 2023, state taxes in California, Illinois, Indiana, New Jersey, Michigan, Pennsylvania, Texas, Florida, Minnesota, and Oregon made up the majority (greater than 50 percent) of the tax effect in this category. | |||||||||||||||||||||||||||||||||||
| (Millions of dollars) Year Ended December 31, | 2025 | 2024 | 2023 | ||||||||||||||
| U.S. Federal | $ | 544 | $ | 503 | $ | 483 | |||||||||||
| State and local | 100 | 106 | 121 | ||||||||||||||
| Non-U.S. | 1,630 | 1,607 | 1,351 | ||||||||||||||
| Total | $ | 2,274 | $ | 2,216 | $ | 1,955 | |||||||||||
| (Millions of dollars) Year Ended December 31, | 2025 | 2024 | 2023 | ||||||||||||||
| United States | $ | 644 | $ | 609 | $ | 604 | |||||||||||
| Germany | 82 | 224 | 236 | ||||||||||||||
| China | 199 | 201 | 187 | ||||||||||||||
| Mexico | 237 | 158 | 138 | ||||||||||||||
| Others | 1,112 | 1,024 | 790 | ||||||||||||||
| Total | $ | 2,274 | $ | 2,216 | $ | 1,955 | |||||||||||
(Millions of dollars) December 31, | 2025 | 2024 | |||||||||
| Deferred tax liabilities | |||||||||||
| Fixed assets | $ | 2,462 | $ | 2,378 | |||||||
| Goodwill | 263 | 233 | |||||||||
| Other intangible assets | 2,672 | 2,638 | |||||||||
| Subsidiary/equity investments | 492 | 535 | |||||||||
| Benefit plans and related (b)(c) | 40 | — | |||||||||
| Other (a) | 488 | 736 | |||||||||
| $ | 6,417 | $ | 6,520 | ||||||||
| Deferred tax assets | |||||||||||
| Carryforwards | $ | 380 | $ | 505 | |||||||
| Benefit plans and related (b)(c) | — | 16 | |||||||||
| Inventory | 87 | 87 | |||||||||
| Accruals and other (d) | 968 | 827 | |||||||||
| $ | 1,435 | $ | 1,435 | ||||||||
| Less: Valuation allowances (e) | (151) | (146) | |||||||||
| $ | 1,284 | $ | 1,289 | ||||||||
| Net deferred tax liabilities | $ | 5,133 | $ | 5,231 | |||||||
Recorded in the consolidated balance sheets as (Note 7): | |||||||||||
| Other long-term assets | 423 | 428 | |||||||||
| Deferred credits | 5,556 | 5,659 | |||||||||
| $ | 5,133 | $ | 5,231 | ||||||||
| (Millions of dollars) | 2025 | 2024 | 2023 | ||||||||||||||
| Balance, January 1, | $ | (146) | $ | (176) | $ | (276) | |||||||||||
| Income tax (charge) benefit | 1 | 26 | 65 | ||||||||||||||
| Other, including write-offs | — | — | 34 | ||||||||||||||
| Translation adjustments | (6) | 4 | 1 | ||||||||||||||
| Balance, December 31, | $ | (151) | $ | (146) | $ | (176) | |||||||||||
| (Millions of dollars) | 2025 | 2024 | 2023 | ||||||||||||||
| Unrecognized income tax benefits, January 1 | $ | 292 | $ | 304 | $ | 325 | |||||||||||
| Additions for tax positions of prior years | 9 | 19 | 108 | ||||||||||||||
| Reductions for tax positions of prior years (a) | (2) | (9) | (121) | ||||||||||||||
| Additions for current year tax positions | 22 | 11 | — | ||||||||||||||
| Reductions for settlements with taxing authorities | (4) | (12) | (1) | ||||||||||||||
| Other (b) | (2) | (21) | (7) | ||||||||||||||
| Unrecognized income tax benefits, December 31 | $ | 315 | $ | 292 | $ | 304 | |||||||||||
| Major tax jurisdictions | Open Years | ||||
| Americas | |||||
| United States | 2022 through 2025 | ||||
| Canada | 2014 through 2025 | ||||
| Mexico | 2014 through 2025 | ||||
| Brazil | 2008 through 2025 | ||||
| EMEA | |||||
| Germany | 2018 through 2025 | ||||
| United Kingdom | 2022 through 2025 | ||||
| APAC | |||||
| Australia | 2021 through 2025 | ||||
| China | 2020 through 2025 | ||||
| India | 2007 through 2025 | ||||
| South Korea | 2020 through 2025 | ||||
| 2025 | 2024 | 2023 | |||||||||||||||
| Numerator (Millions of dollars) | |||||||||||||||||
| Net Income – Linde plc | $ | 6,898 | $ | 6,565 | $ | 6,199 | |||||||||||
| Denominator (Thousands of shares) | |||||||||||||||||
| Weighted average shares outstanding | 468,673 | 477,998 | 487,656 | ||||||||||||||
| Shares earned and issuable under compensation plans | 815 | 775 | 535 | ||||||||||||||
| Weighted average shares used in basic earnings per share | 469,488 | 478,773 | 488,191 | ||||||||||||||
| Effect of dilutive securities | |||||||||||||||||
| Stock options and awards | 2,707 | 3,319 | 4,099 | ||||||||||||||
| Weighted average shares used in diluted earnings per share | 472,195 | 482,092 | 492,290 | ||||||||||||||
| Basic Earnings Per Share | $ | 14.69 | $ | 13.71 | $ | 12.70 | |||||||||||
| Diluted Earnings Per Share | $ | 14.61 | $ | 13.62 | $ | 12.59 | |||||||||||
(Millions of dollars) Year Ended December 31, | 2025 | 2024 | 2023 | ||||||||||||||
| Selling, General and Administrative | |||||||||||||||||
| Selling | $ | 1,350 | $ | 1,333 | $ | 1,330 | |||||||||||
| General and administrative | 2,083 | 2,004 | 1,965 | ||||||||||||||
| $ | 3,433 | $ | 3,337 | $ | 3,295 | ||||||||||||
| Year Ended December 31, | 2025 | 2024 | 2023 | ||||||||||||||
| Depreciation and Amortization (a) | |||||||||||||||||
| Depreciation | $ | 3,246 | $ | 3,226 | $ | 3,266 | |||||||||||
Amortization of intangibles (Note 10) | 517 | 554 | 550 | ||||||||||||||
| Depreciation and Amortization | $ | 3,763 | $ | 3,780 | $ | 3,816 | |||||||||||
| Year Ended December 31, | 2025 | 2024 | 2023 | ||||||||||||||
| Other Income (Expenses) – Net | |||||||||||||||||
| Currency related net gains (losses) | $ | (13) | $ | (11) | $ | (47) | |||||||||||
| Partnership income | 2 | 3 | 2 | ||||||||||||||
| Severance expense | (16) | (16) | (12) | ||||||||||||||
| Asset divestiture gains (losses) – net | 34 | 77 | 21 | ||||||||||||||
| Insurance recoveries | 2 | 45 | 10 | ||||||||||||||
| Purchase accounting impacts - Linde AG merger | (164) | (17) | (15) | ||||||||||||||
| Other – net gains (losses) | 97 | 104 | — | ||||||||||||||
| $ | (58) | $ | 185 | $ | (41) | ||||||||||||
Year Ended December 31, | 2025 | 2024 | 2023 | ||||||||||||||
| Interest Expense – Net | |||||||||||||||||
| Interest incurred on debt and other | $ | 575 | $ | 555 | $ | 480 | |||||||||||
| Interest income | (209) | (228) | (197) | ||||||||||||||
| Amortization on acquired debt | — | (3) | (16) | ||||||||||||||
| Interest capitalized | (111) | (68) | (67) | ||||||||||||||
| $ | 255 | $ | 256 | $ | 200 | ||||||||||||
(Millions of dollars) December 31, | 2025 | 2024 | |||||||||
| Accounts Receivable | |||||||||||
| Trade and Other receivables | $ | 5,547 | $ | 5,043 | |||||||
| Less: allowance for expected credit losses | (581) | (421) | |||||||||
| $ | 4,966 | $ | 4,622 | ||||||||
December 31, | 2025 | 2024 | |||||||||
| Inventories | |||||||||||
| Raw materials and supplies | $ | 530 | $ | 529 | |||||||
| Work in process | 346 | 371 | |||||||||
| Finished goods | 1,179 | 1,046 | |||||||||
| $ | 2,055 | $ | 1,946 | ||||||||
| December 31, | 2025 | 2024 | |||||||||
| Prepaid and Other Current Assets | |||||||||||
| Prepaid and other deferred charges (b) | $ | 546 | $ | 579 | |||||||
| VAT recoverable | 229 | 177 | |||||||||
Unrealized gains on derivatives (Note 12) | 107 | 302 | |||||||||
| Other (c) | 97 | 206 | |||||||||
| $ | 979 | $ | 1,264 | ||||||||
| December 31, | 2025 | 2024 | |||||||||
| Other Long-term Assets | |||||||||||
Pension assets (Note 16) | $ | 1,298 | $ | 1,106 | |||||||
| Insurance contracts (d) | 32 | 32 | |||||||||
| Long-term receivables, net (e) | 29 | 28 | |||||||||
Lease assets (Note 4) | 1,079 | 989 | |||||||||
| Deposits | 62 | 73 | |||||||||
| Investments carried at cost (f) (Note 17) | 108 | 106 | |||||||||
| Deferred charges | 63 | 58 | |||||||||
Deferred income taxes (Note 5) | 423 | 428 | |||||||||
Unrealized gains on derivatives (Note 12) | 10 | 4 | |||||||||
| Contract assets (Note 19) | 67 | — | |||||||||
| Other | 248 | 206 | |||||||||
| $ | 3,419 | $ | 3,030 | ||||||||
| December 31, | 2025 | 2024 | |||||||||
| Other Current Liabilities | |||||||||||
| Accrued expenses | $ | 1,278 | $ | 1,321 | |||||||
| Payroll | 649 | 618 | |||||||||
| VAT payable | 342 | 256 | |||||||||
Pension and postretirement (Note 16) | 41 | 37 | |||||||||
| Interest payable | 310 | 227 | |||||||||
Lease liability (Note 4) | 261 | 230 | |||||||||
| Insurance reserves | 21 | 20 | |||||||||
Unrealized losses on derivatives (Note 12) | 72 | 92 | |||||||||
Contingent liabilities (Note 17) | 128 | 167 | |||||||||
Cost reduction programs and other charges (Note 3) | 255 | 175 | |||||||||
| Other | 814 | 783 | |||||||||
| $ | 4,171 | $ | 3,926 | ||||||||
| December 31, | 2025 | 2024 | |||||||||
| Other Long-term Liabilities | |||||||||||
Pension and postretirement (Note 16) | $ | 473 | $ | 519 | |||||||
Tax liabilities for uncertain tax positions (Note 5) | 230 | 210 | |||||||||
Lease liability (Note 4) | 819 | 756 | |||||||||
Interest and penalties for uncertain tax positions (Note 5) | 19 | 16 | |||||||||
| Insurance reserves | 63 | 60 | |||||||||
| Asset retirement obligation | 318 | 305 | |||||||||
Unrealized losses on derivatives (Note 12) | 2 | 9 | |||||||||
Cost reduction programs and other charges (Note 3) | 183 | 66 | |||||||||
Contingent liabilities (Note 17) | 1,828 | 1,646 | |||||||||
| Other | 420 | 428 | |||||||||
| $ | 4,355 | $ | 4,015 | ||||||||
| December 31, | 2025 | 2024 | |||||||||
| Deferred Credits | |||||||||||
Deferred income taxes (Note 5) | $ | 5,556 | $ | 5,659 | |||||||
Contract liabilities (Note 19) | 1,284 | 1,098 | |||||||||
| $ | 6,840 | $ | 6,757 | ||||||||
| December 31, | 2025 | 2024 | |||||||||
| Accumulated Other Comprehensive Income (Loss) | |||||||||||
| Cumulative translation adjustment - net of taxes: | |||||||||||
| Americas (g) | $ | (3,892) | $ | (4,422) | |||||||
| EMEA (g) | (958) | (1,235) | |||||||||
| APAC (g) | (1,170) | (1,736) | |||||||||
| Engineering | 283 | (432) | |||||||||
| Other | (616) | 858 | |||||||||
| (6,353) | (6,967) | ||||||||||
| Derivatives – net of taxes | 16 | (6) | |||||||||
Pension/OPEB funded status obligation (net of $102 million tax obligation in 2025 and $95 million tax obligation in 2024) (Note 16) | 104 | 79 | |||||||||
| $ | (6,233) | $ | (6,894) | ||||||||
(Millions of dollars) December 31, | Depreciable Lives (Yrs) | 2025 | 2024 | |||||||||||||||||
| Production plants (primarily 15-year life) (a) | 10-20 | $ | 40,301 | $ | 35,364 | |||||||||||||||
| Storage tanks | 15-20 | 6,215 | 5,689 | |||||||||||||||||
| Transportation equipment and other | 3-15 | 4,872 | 4,210 | |||||||||||||||||
| Cylinders | 10-30 | 5,542 | 4,970 | |||||||||||||||||
| Buildings | 25-40 | 3,831 | 3,355 | |||||||||||||||||
| Land and improvements (b) | 0-20 | 1,188 | 1,045 | |||||||||||||||||
| Construction in progress | 6,130 | 4,086 | ||||||||||||||||||
| 68,079 | 58,719 | |||||||||||||||||||
| Less: accumulated depreciation | (39,819) | (33,944) | ||||||||||||||||||
| $ | 28,260 | $ | 24,775 | |||||||||||||||||
| (Millions of dollars) | Americas | EMEA | APAC | Engineering | Other | Total | |||||||||||||||||||||||||||||
| Balance, December 31, 2023 | $ | 9,703 | $ | 9,834 | $ | 4,499 | $ | 2,422 | $ | 293 | $ | 26,751 | |||||||||||||||||||||||
| Acquisitions (Note 2) | 191 | — | 17 | — | — | 208 | |||||||||||||||||||||||||||||
| Foreign currency translation and other | (56) | (538) | (253) | (150) | (21) | (1,018) | |||||||||||||||||||||||||||||
| Disposals (Note 2) | — | — | (4) | — | — | (4) | |||||||||||||||||||||||||||||
| Balance, December 31, 2024 | 9,838 | 9,296 | 4,259 | 2,272 | 272 | 25,937 | |||||||||||||||||||||||||||||
| Acquisitions (Note 2) | 31 | 120 | 99 | — | 2 | 252 | |||||||||||||||||||||||||||||
| Foreign currency translation and other | 41 | 1,137 | 243 | 306 | 11 | 1,738 | |||||||||||||||||||||||||||||
| Balance, December 31, 2025 | $ | 9,910 | $ | 10,553 | $ | 4,601 | $ | 2,578 | $ | 285 | $ | 27,927 | |||||||||||||||||||||||
(Millions of dollars) For the year ended December 31, 2025 | Customer Relationships | Brands/Tradenames | Other Intangible Assets | Total | |||||||||||||||||||
| Cost: | |||||||||||||||||||||||
| Balance, December 31, 2024 | $ | 10,972 | $ | 2,504 | $ | 1,934 | $ | 15,410 | |||||||||||||||
| Additions | 78 | — | 35 | 113 | |||||||||||||||||||
| Foreign currency translation | 913 | 191 | 168 | 1,272 | |||||||||||||||||||
| Disposals | (1) | — | (10) | (11) | |||||||||||||||||||
| Other * | (5) | (5) | 78 | 68 | |||||||||||||||||||
| Balance, December 31, 2025 | 11,957 | 2,690 | 2,205 | 16,852 | |||||||||||||||||||
| Less: accumulated amortization: | |||||||||||||||||||||||
| Balance, December 31, 2024 | (2,571) | (265) | (1,244) | (4,080) | |||||||||||||||||||
| Amortization expense (Note 7) | (394) | (25) | (98) | (517) | |||||||||||||||||||
| Foreign currency translation | (224) | (8) | (102) | (334) | |||||||||||||||||||
| Disposals | — | — | 10 | 10 | |||||||||||||||||||
| Other * | 5 | 5 | (70) | (60) | |||||||||||||||||||
| Balance, December 31, 2025 | (3,184) | (293) | (1,504) | (4,981) | |||||||||||||||||||
| Net Balance, December 31, 2025 | $ | 8,773 | $ | 2,397 | $ | 701 | $ | 11,871 | |||||||||||||||
(Millions of dollars) For the year ended December 31, 2024 | Customer Relationships | Brands/Tradenames | Other Intangible Assets | Total | |||||||||||||||||||
| Cost: | |||||||||||||||||||||||
| Balance, December 31, 2023 | $ | 11,479 | $ | 2,609 | $ | 1,913 | $ | 16,001 | |||||||||||||||
| Additions | 22 | — | 28 | 50 | |||||||||||||||||||
| Foreign currency translation | (530) | (107) | (113) | (750) | |||||||||||||||||||
| Disposals | (10) | (2) | (48) | (60) | |||||||||||||||||||
| Other * | 11 | 4 | 154 | 169 | |||||||||||||||||||
| Balance, December 31, 2024 | 10,972 | 2,504 | 1,934 | 15,410 | |||||||||||||||||||
| Less: accumulated amortization: | |||||||||||||||||||||||
| Balance, December 31, 2023 | (2,270) | (233) | (1,099) | (3,602) | |||||||||||||||||||
| Amortization expense (Note 7) | (416) | (36) | (102) | (554) | |||||||||||||||||||
| Foreign currency translation | 116 | 5 | 66 | 187 | |||||||||||||||||||
| Disposals | 2 | — | 42 | 44 | |||||||||||||||||||
| Other * | (3) | (1) | (151) | (155) | |||||||||||||||||||
| Balance, December 31, 2024 | (2,571) | (265) | (1,244) | (4,080) | |||||||||||||||||||
| Net balance at December 31, 2024 | $ | 8,401 | $ | 2,239 | $ | 690 | $ | 11,330 | |||||||||||||||
| (Millions of dollars) | |||||
| 2026 | $ | 615 | |||
| 2027 | 598 | ||||
| 2028 | 580 | ||||
| 2029 | 575 | ||||
| 2030 | 574 | ||||
| Thereafter | 7,103 | ||||
| Total amortization related to finite-lived intangible assets | 10,045 | ||||
| Indefinite-lived intangible assets at December 31, 2025 | 1,826 | ||||
| Net intangible assets at December 31, 2025 | $ | 11,871 | |||
| (Millions of dollars) | |||||||||||
| December 31, | 2025 | 2024 | |||||||||
| SHORT-TERM | |||||||||||
| Commercial paper | $ | 4,226 | $ | 3,964 | |||||||
| Other bank borrowings (primarily non U.S.) | 284 | 259 | |||||||||
| Total short-term debt | 4,510 | 4,223 | |||||||||
| LONG-TERM (a) | |||||||||||
| (U.S. dollar denominated unless otherwise noted) | |||||||||||
4.700% Notes due 2025 (d) | — | 599 | |||||||||
2.65% Notes due 2025 (d) | — | 400 | |||||||||
3.625% Euro denominated notes due 2025 (f) | — | 517 | |||||||||
1.625% Euro denominated notes due 2025 (h) | — | 517 | |||||||||
0.00% Euro denominated notes due 2026 | 822 | 726 | |||||||||
3.20% Notes due 2026 | 725 | 725 | |||||||||
3.434% Notes due 2026 | 200 | 199 | |||||||||
1.652% Euro denominated notes due 2027 | 95 | 84 | |||||||||
0.250% Euro denominated notes due 2027 | 880 | 776 | |||||||||
1.00% Euro denominated notes due 2027 | 589 | 519 | |||||||||
2.271% Euro denominated notes due 2027 (g) | 705 | — | |||||||||
1.00% Euro denominated notes due 2028 (b) | 854 | 742 | |||||||||
3.00% Euro denominated notes due 2028 | 820 | 722 | |||||||||
3.375% Euro denominated notes due 2029 | 878 | 773 | |||||||||
2.625% Euro denominated notes due 2029 (c) | 994 | — | |||||||||
0.6150% Swiss franc denominated notes due 2029 (e) | 283 | — | |||||||||
1.10% Notes due 2030 | 698 | 697 | |||||||||
1.90% Euro denominated notes due 2030 | 120 | 106 | |||||||||
3.375% Euro denominated notes due 2030 | 877 | 772 | |||||||||
1.375% Euro denominated notes due 2031 | 884 | 779 | |||||||||
3.20% Euro denominated notes due 2031 | 997 | 878 | |||||||||
0.550% Euro denominated notes due 2032 | 877 | 772 | |||||||||
3.125% Euro denominated notes due 2032 (g) | 759 | — | |||||||||
0.375% Euro denominated notes due 2033 | 582 | 512 | |||||||||
3.00% Euro denominated notes due 2033 (c) | 877 | — | |||||||||
1.0629% Swiss franc denominated notes due 2033 (e) | 346 | — | |||||||||
3.625% Euro denominated notes due 2034 | 760 | 670 | |||||||||
3.50% Euro denominated notes due 2034 | 874 | 769 | |||||||||
1.625% Euro denominated notes due 2035 | 934 | 822 | |||||||||
3.40% Euro denominated notes due 2036 | 816 | 718 | |||||||||
3.250% Euro denominated notes due 2037 (c) | 756 | — | |||||||||
3.750% Euro denominated notes due 2038 (g) | 582 | — | |||||||||
3.55% Notes due 2042 | 666 | 666 | |||||||||
3.75% Euro denominated notes due 2044 | 810 | 712 | |||||||||
2.00% Notes due 2050 | 297 | 297 | |||||||||
1.00% Euro denominated notes due 2051 | 805 | 707 | |||||||||
| Non U.S. borrowings | 307 | 214 | |||||||||
| Other | 10 | 10 | |||||||||
| 22,479 | 17,400 | ||||||||||
| Less: current portion of long-term debt | (1,796) | (2,057) | |||||||||
| Total long-term debt | 20,683 | 15,343 | |||||||||
| Total debt | $ | 26,989 | $ | 21,623 | |||||||
| (Millions of dollars) | |||||
| 2026 | $ | 1,796 | |||
| 2027 | 2,311 | ||||
| 2028 | 1,730 | ||||
| 2029 | 2,168 | ||||
| 2030 | 1,708 | ||||
| Thereafter | 12,766 | ||||
| $ | 22,479 | ||||
| Fair Value | |||||||||||||||||||||||||||||||||||
| (Millions of dollars) | Notional Amounts | Assets (a) | Liabilities (a) | ||||||||||||||||||||||||||||||||
| December 31, | 2025 | 2024 | 2025 | 2024 | 2025 | 2024 | |||||||||||||||||||||||||||||
| Derivatives Not Designated as Hedging Instruments: | |||||||||||||||||||||||||||||||||||
| Currency contracts: | |||||||||||||||||||||||||||||||||||
| Balance sheet items | $ | 9,509 | $ | 9,935 | $ | 79 | $ | 256 | $ | 34 | $ | 64 | |||||||||||||||||||||||
Forecasted transactions | 164 | 168 | 3 | 2 | 1 | 6 | |||||||||||||||||||||||||||||
| Total | $ | 9,673 | $ | 10,103 | $ | 82 | $ | 258 | $ | 35 | $ | 70 | |||||||||||||||||||||||
| Derivatives Designated as Hedging Instruments: | |||||||||||||||||||||||||||||||||||
| Currency contracts: | |||||||||||||||||||||||||||||||||||
| Forecasted transactions | $ | 560 | $ | 780 | $ | 24 | $ | 7 | $ | 1 | $ | 11 | |||||||||||||||||||||||
| Forward exchange contracts | 3,420 | 1,059 | 6 | 30 | 28 | — | |||||||||||||||||||||||||||||
| Commodity contracts | N/A | N/A | 5 | 11 | 10 | 20 | |||||||||||||||||||||||||||||
| Total Hedges | $ | 3,980 | $ | 1,839 | $ | 35 | $ | 48 | $ | 39 | $ | 31 | |||||||||||||||||||||||
| Total Derivatives | $ | 13,653 | $ | 11,942 | $ | 117 | $ | 306 | $ | 74 | $ | 101 | |||||||||||||||||||||||
| (Millions of dollars) | Amount of Pre-Tax Gain (Loss) Recognized in Earnings * | ||||||||||||||||
| Year Ended December 31, | 2025 | 2024 | 2023 | ||||||||||||||
| Derivatives Not Designated as Hedging Instruments | |||||||||||||||||
| Currency contracts: | |||||||||||||||||
| Balance sheet items: | |||||||||||||||||
| Debt-related | $ | (65) | $ | 88 | $ | 91 | |||||||||||
| Other balance sheet items | 6 | — | (1) | ||||||||||||||
| Total | $ | (59) | $ | 88 | $ | 90 | |||||||||||
| Fair Value Measurements Using | |||||||||||||||||||||||||||||||||||
| (Millions of dollars) | Level 1 | Level 2 | Level 3 | ||||||||||||||||||||||||||||||||
| 2025 | 2024 | 2025 | 2024 | 2025 | 2024 | ||||||||||||||||||||||||||||||
| Assets | |||||||||||||||||||||||||||||||||||
| Derivative assets | $ | — | $ | — | $ | 117 | $ | 306 | $ | — | $ | — | |||||||||||||||||||||||
| Investments and securities * | 20 | 16 | — | — | 13 | 12 | |||||||||||||||||||||||||||||
| Total | $ | 20 | $ | 16 | $ | 117 | $ | 306 | $ | 13 | $ | 12 | |||||||||||||||||||||||
| Liabilities | |||||||||||||||||||||||||||||||||||
| Derivative liabilities | $ | — | $ | — | $ | 74 | $ | 101 | $ | — | $ | — | |||||||||||||||||||||||
| Year Ended December 31, | 2025 | 2024 | 2023 | ||||||||||||||
| Dividend yield | 1.3 | % | 1.2 | % | 1.4 | % | |||||||||||
| Volatility | 21.9 | % | 22.5 | % | 22.0 | % | |||||||||||
| Risk-free interest rate | 4.05 | % | 4.01 | % | 4.23 | % | |||||||||||
| Expected term years | 5 | 5 | 5 | ||||||||||||||
| Activity | Number of Options (000’s) | Average Exercise Price | Average Remaining Life | Aggregate Intrinsic Value | |||||||||||||||||||
| Outstanding at January 1, 2025 | 5,023 | $ | 204.50 | ||||||||||||||||||||
| Granted | 317 | 468.77 | |||||||||||||||||||||
| Exercised | (842) | 146.09 | |||||||||||||||||||||
| Cancelled or expired | (18) | 407.03 | |||||||||||||||||||||
| Outstanding at December 31, 2025 | 4,480 | $ | 233.38 | 4.4 | $ | 889 | |||||||||||||||||
| Exercisable at December 31, 2025 | 3,865 | $ | 199.39 | 3.7 | $ | 881 | |||||||||||||||||
| Performance-Based | Restricted Stock | ||||||||||||||||||||||
| Number of Shares (000’s) | Average Grant Date Fair Value | Number of Shares (000’s) | Average Grant Date Fair Value | ||||||||||||||||||||
| Non-vested at January 1, 2025 | 558 | $ | 339.50 | 591 | $ | 271.59 | |||||||||||||||||
| Granted | 237 | 550.48 | 137 | 450.68 | |||||||||||||||||||
| Vested | (272) | 274.73 | (149) | 252.66 | |||||||||||||||||||
| Cancelled and Forfeited | (6) | 534.96 | (13) | 411.61 | |||||||||||||||||||
| Non-vested at December 31, 2025 | 517 | $ | 403.69 | 566 | $ | 316.24 | |||||||||||||||||
| (Millions of dollars) | Year Ended December 31, | ||||||||||||||||
| 2025 | 2024 | 2023 | |||||||||||||||
| Amount recognized in Operating Profit | |||||||||||||||||
| Service cost | $ | 82 | $ | 84 | $ | 84 | |||||||||||
| Amount recognized in Net pension and OPEB cost (benefit), excluding service cost | |||||||||||||||||
| Interest cost | 356 | 362 | 373 | ||||||||||||||
| Expected return on plan assets | (557) | (552) | (523) | ||||||||||||||
| Net amortization and deferral | (30) | (10) | (30) | ||||||||||||||
| Settlement charges (a) | 2 | 10 | 16 | ||||||||||||||
| $ | (229) | $ | (190) | $ | (164) | ||||||||||||
| Net periodic benefit cost (benefit) | $ | (147) | $ | (106) | $ | (80) | |||||||||||
| (Millions of dollars) | Year Ended December 31, | ||||||||||||||||||||||
| 2025 | 2024 | ||||||||||||||||||||||
| U.S. | Non-U.S. | U.S. | Non-U.S. | ||||||||||||||||||||
| Change in Benefit Obligation ("PBO") | |||||||||||||||||||||||
| Benefit obligation, January 1 | $ | 2,090 | $ | 5,486 | $ | 2,187 | $ | 6,385 | |||||||||||||||
| Service cost | 28 | 54 | 28 | 56 | |||||||||||||||||||
| Interest cost | 104 | 252 | 103 | 259 | |||||||||||||||||||
| Participant contributions | 8 | 17 | 11 | 18 | |||||||||||||||||||
| Actuarial loss (gain) | 79 | 9 | (73) | (622) | |||||||||||||||||||
| Benefits paid | (160) | (347) | (155) | (348) | |||||||||||||||||||
| Plan settlement | (5) | (27) | (11) | (14) | |||||||||||||||||||
| Foreign currency translation and other changes | — | 539 | — | (248) | |||||||||||||||||||
| Benefit obligation, December 31 | $ | 2,144 | $ | 5,983 | $ | 2,090 | $ | 5,486 | |||||||||||||||
| Accumulated benefit obligation ("ABO") | $ | 2,018 | $ | 5,891 | $ | 1,964 | $ | 5,405 | |||||||||||||||
| Change in Plan Assets | |||||||||||||||||||||||
| Fair value of plan assets, January 1 | $ | 2,176 | $ | 5,950 | $ | 2,050 | $ | 6,178 | |||||||||||||||
| Actual return on plan assets | 283 | 387 | 267 | 271 | |||||||||||||||||||
| Company contributions | — | 25 | — | 35 | |||||||||||||||||||
| Participant contributions | — | 17 | — | 18 | |||||||||||||||||||
| Benefits paid from plan assets | (146) | (333) | (141) | (321) | |||||||||||||||||||
| Foreign currency translation and other changes | — | 552 | — | (231) | |||||||||||||||||||
| Fair value of plan assets, December 31 | $ | 2,313 | $ | 6,598 | $ | 2,176 | $ | 5,950 | |||||||||||||||
| Funded Status, End of Year | $ | 169 | $ | 615 | $ | 86 | $ | 464 | |||||||||||||||
Recorded in the Balance Sheet (Note 7) | |||||||||||||||||||||||
| Other long-term assets | $ | 293 | $ | 1,005 | $ | 212 | $ | 894 | |||||||||||||||
| Other current liabilities | (17) | (24) | (16) | (21) | |||||||||||||||||||
| Other long-term liabilities | (107) | (366) | (110) | (409) | |||||||||||||||||||
| Net amount recognized, December 31 | $ | 169 | $ | 615 | $ | 86 | $ | 464 | |||||||||||||||
| Amounts recognized in accumulated other comprehensive income (loss) consist of: | |||||||||||||||||||||||
| Net actuarial loss (gain) | $ | 35 | $ | (233) | $ | 91 | $ | (256) | |||||||||||||||
| Prior service cost (credit) | (8) | — | (9) | — | |||||||||||||||||||
Deferred tax obligation (benefit) (Note 7) | (7) | 109 | (21) | 116 | |||||||||||||||||||
Amount recognized in accumulated other comprehensive income (loss) (Note 7) | $ | 20 | $ | (124) | $ | 61 | $ | (140) | |||||||||||||||
| United Kingdom | Germany | Other Non-U.S. | Total Non-U.S. | ||||||||||||||||||||
| (Millions of dollars) | 2025 | 2025 | 2025 | 2025 | |||||||||||||||||||
| Benefit obligation, December 31 | $ | 3,213 | $ | 1,690 | $ | 1,080 | $ | 5,983 | |||||||||||||||
| Fair value of plan assets, December 31 | 3,979 | 1,624 | 995 | 6,598 | |||||||||||||||||||
| Funded Status, End of Year | $ | 766 | $ | (66) | $ | (85) | $ | 615 | |||||||||||||||
| United Kingdom | Germany | Other Non-U.S. | Total Non-U.S. | ||||||||||||||||||||
| (Millions of dollars) | 2024 | 2024 | 2024 | 2024 | |||||||||||||||||||
| Benefit obligation, December 31 | $ | 2,883 | $ | 1,594 | $ | 1,009 | $ | 5,486 | |||||||||||||||
| Fair value of plan assets, December 31 | 3,640 | 1,418 | 892 | 5,950 | |||||||||||||||||||
| Funded Status, End of Year | $ | 757 | $ | (176) | $ | (117) | $ | 464 | |||||||||||||||
| Pensions | |||||||||||
| (Millions of dollars) | 2025 | 2024 | |||||||||
| Current year net actuarial losses (gains)* | $ | (25) | $ | (681) | |||||||
| Amortization of net actuarial gains (losses) | 29 | 9 | |||||||||
| Amortization of prior service credits (costs) | 1 | 1 | |||||||||
| Pension settlements | (2) | (10) | |||||||||
| Foreign currency translation and other changes | (35) | 7 | |||||||||
| Total recognized in other comprehensive income | $ | (32) | $ | (674) | |||||||
(Millions of dollars) Year Ended December 31, | Pensions | ||||||||||||||||||||||
| 2025 | 2024 | ||||||||||||||||||||||
| U.S. | Non-U.S. | U.S. | Non-U.S. | ||||||||||||||||||||
| Accumulated benefit obligation ("ABO") | $ | 44 | $ | 678 | $ | 44 | $ | 1,746 | |||||||||||||||
| Fair value of plan assets | $ | — | $ | 347 | $ | — | $ | 1,384 | |||||||||||||||
(Millions of dollars) Year Ended December 31, | Pensions | ||||||||||||||||||||||
| 2025 | 2024 | ||||||||||||||||||||||
| U.S. | Non-U.S. | U.S. | Non-U.S. | ||||||||||||||||||||
| Projected benefit obligation ("PBO") | $ | 49 | $ | 711 | $ | 47 | $ | 1,796 | |||||||||||||||
| Fair value of plan assets | $ | — | $ | 354 | $ | — | $ | 1,391 | |||||||||||||||
| Pensions | |||||||||||||||||||||||
| U.S. | Non-U.S. | ||||||||||||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||||||||||||
| Weighted average assumptions used to determine benefit obligations at December 31, | |||||||||||||||||||||||
| Discount rate | 5.27 | % | 5.55 | % | 4.96 | % | 4.76 | % | |||||||||||||||
| Interest crediting rate | 4.74 | % | 4.68 | % | 1.32 | % | 1.11 | % | |||||||||||||||
| Rate of increase in compensation levels | 3.50 | % | 3.50 | % | 2.53 | % | 2.55 | % | |||||||||||||||
| Weighted average assumptions used to determine net periodic benefit cost for years ended December 31, | |||||||||||||||||||||||
| Discount rate | 5.55 | % | 5.03 | % | 4.76 | % | 4.27 | % | |||||||||||||||
| Interest crediting rate | 4.68 | % | 4.03 | % | 1.11 | % | 1.70 | % | |||||||||||||||
| Rate of increase in compensation levels | 3.50 | % | 3.50 | % | 2.55 | % | 2.58 | % | |||||||||||||||
| Expected long-term rate of return on plan assets (1) | 7.00 | % | 7.00 | % | 6.01 | % | 6.02 | % | |||||||||||||||
| U.S. | Non-U.S. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Asset Category | Target 2025 | Target 2024 | 2025 | 2024 | Target 2025 | Target 2024 | 2025 | 2024 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Equity securities | 50% | - | 70% | 50% | - | 70% | 66% | 62% | 20% | - | 40% | 15% | - | 25% | 32% | 24% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Fixed income securities | 20% | - | 50% | 20% | - | 50% | 29% | 31% | 30% | - | 50% | 30% | - | 50% | 35% | 29% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Other | 2% | - | 8% | 2% | - | 8% | 5% | 7% | 5% | - | 25% | 30% | - | 50% | 33% | 47% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Fair Value Measurements Using | |||||||||||||||||||||||||||||||||||||||||||||||
| Level 1 | Level 2 | Level 3 ** | Total | ||||||||||||||||||||||||||||||||||||||||||||
| (Millions of dollars) | 2025 | 2024 | 2025 | 2024 | 2025 | 2024 | 2025 | 2024 | |||||||||||||||||||||||||||||||||||||||
| Cash and cash equivalents | $ | 315 | $ | 407 | $ | — | $ | — | $ | — | $ | — | $ | 315 | $ | 407 | |||||||||||||||||||||||||||||||
| Equity securities: | |||||||||||||||||||||||||||||||||||||||||||||||
| Global equities | 4 | 1,149 | — | — | — | — | 4 | 1,149 | |||||||||||||||||||||||||||||||||||||||
| Mutual funds | 1,129 | 344 | — | — | — | — | 1,129 | 344 | |||||||||||||||||||||||||||||||||||||||
| Fixed income securities: | |||||||||||||||||||||||||||||||||||||||||||||||
| Government bonds | — | — | 1,052 | 1,304 | — | — | 1,052 | 1,304 | |||||||||||||||||||||||||||||||||||||||
| Emerging market debt | — | — | 291 | 294 | — | — | 291 | 294 | |||||||||||||||||||||||||||||||||||||||
| Mutual funds | — | 130 | 279 | 61 | — | — | 279 | 191 | |||||||||||||||||||||||||||||||||||||||
| Corporate bonds | — | — | 659 | 401 | — | — | 659 | 401 | |||||||||||||||||||||||||||||||||||||||
| Bank loans | — | — | 9 | 25 | — | — | 9 | 25 | |||||||||||||||||||||||||||||||||||||||
| Alternative investments: | |||||||||||||||||||||||||||||||||||||||||||||||
| Real estate funds | — | — | — | — | 337 | 314 | 337 | 314 | |||||||||||||||||||||||||||||||||||||||
| Private debt | — | — | — | — | 1,071 | 1,048 | 1,071 | 1,048 | |||||||||||||||||||||||||||||||||||||||
| Insurance contracts | — | — | — | — | 64 | 54 | 64 | 54 | |||||||||||||||||||||||||||||||||||||||
| Liquid alternatives | — | — | 780 | 1,087 | — | — | 780 | 1,087 | |||||||||||||||||||||||||||||||||||||||
| Other investments | 1 | 2 | 27 | 23 | — | — | 28 | 25 | |||||||||||||||||||||||||||||||||||||||
| Total plan assets at fair value, December 31, | $ | 1,449 | $ | 2,032 | $ | 3,097 | $ | 3,195 | $ | 1,472 | $ | 1,416 | $ | 6,018 | $ | 6,643 | |||||||||||||||||||||||||||||||
| Pooled funds * | 2,893 | 1,483 | |||||||||||||||||||||||||||||||||||||||||||||
| Total fair value plan assets December 31, | $ | 8,911 | $ | 8,126 | |||||||||||||||||||||||||||||||||||||||||||
| (Millions of dollars) | Insurance Contracts | Real Estate Funds | Private Debt | Total | |||||||||||||||||||
Balance, December 31, 2023 | $ | 51 | $ | 324 | $ | 1,345 | $ | 1,720 | |||||||||||||||
| Gain/(Loss) for the period | 3 | 10 | (12) | 1 | |||||||||||||||||||
| Purchases | 4 | 28 | — | 32 | |||||||||||||||||||
| Sales | — | (37) | (255) | (292) | |||||||||||||||||||
| Transfer into/ (out of) Level 3 | — | — | — | — | |||||||||||||||||||
| Foreign currency translation | (4) | (11) | (30) | (45) | |||||||||||||||||||
Balance, December 31, 2024 | 54 | 314 | 1,048 | 1,416 | |||||||||||||||||||
| Gain/(Loss) for the period | 1 | 35 | (14) | 22 | |||||||||||||||||||
| Purchases | 3 | — | 5 | 8 | |||||||||||||||||||
| Sales | — | (34) | (61) | (95) | |||||||||||||||||||
| Transfer into / (out of) Level 3 | — | — | — | — | |||||||||||||||||||
| Foreign currency translation | 6 | 22 | 93 | 121 | |||||||||||||||||||
Balance, December 31, 2025 | $ | 64 | $ | 337 | $ | 1,071 | $ | 1,472 | |||||||||||||||
| (Millions of dollars) | Pensions | ||||||||||
| Year Ended December 31, | U.S. | Non-U.S. | |||||||||
| 2026 | $ | 217 | $ | 406 | |||||||
| 2027 | 167 | 508 | |||||||||
| 2028 | 166 | 407 | |||||||||
| 2029 | 168 | 413 | |||||||||
| 2030 | 170 | 424 | |||||||||
| Thereafter | 843 | 2,247 | |||||||||
| (Millions of dollars) | Americas | EMEA | APAC | Engineering | Other | Total | ||||||||||||||||||||||||||||||||
| 2025 | ||||||||||||||||||||||||||||||||||||||
| Sales (a) | $ | 15,208 | $ | 8,549 | $ | 6,661 | $ | 2,250 | $ | 1,318 | $ | 33,986 | ||||||||||||||||||||||||||
| Variable Costs (b) | 5,763 | 2,943 | 3,270 | 853 | 484 | 13,313 | ||||||||||||||||||||||||||||||||
| Fixed Costs and other (c) | 3,194 | 1,870 | 784 | 957 | 745 | 7,550 | ||||||||||||||||||||||||||||||||
| Depreciation and amortization (d) | 1,504 | 681 | 674 | 32 | 95 | 2,986 | ||||||||||||||||||||||||||||||||
| Operating Profit (e) | 4,747 | 3,055 | 1,933 | 408 | (6) | 10,137 | ||||||||||||||||||||||||||||||||
| Expenditures for long-lived assets | $ | 3,428 | $ | 729 | $ | 1,177 | $ | 35 | $ | 304 | $ | 5,673 | ||||||||||||||||||||||||||
| 2024 | ||||||||||||||||||||||||||||||||||||||
| Sales (a) | $ | 14,442 | $ | 8,352 | $ | 6,632 | $ | 2,322 | $ | 1,257 | $ | 33,005 | ||||||||||||||||||||||||||
| Variable Costs (b) | 5,375 | 3,129 | 3,304 | 920 | 408 | 13,136 | ||||||||||||||||||||||||||||||||
| Fixed Costs and other (c) | 3,067 | 1,803 | 769 | 959 | 694 | 7,292 | ||||||||||||||||||||||||||||||||
| Depreciation and amortization (d) | 1,450 | 640 | 641 | 33 | 93 | 2,857 | ||||||||||||||||||||||||||||||||
| Operating Profit (e) | 4,550 | 2,780 | 1,918 | 410 | 62 | 9,720 | ||||||||||||||||||||||||||||||||
| Expenditures for long-lived assets | $ | 2,805 | $ | 702 | $ | 1,059 | $ | 25 | $ | 223 | $ | 4,814 | ||||||||||||||||||||||||||
| 2023 | ||||||||||||||||||||||||||||||||||||||
| Sales (a) | $ | 14,304 | $ | 8,542 | $ | 6,559 | $ | 2,160 | $ | 1,289 | $ | 32,854 | ||||||||||||||||||||||||||
| Variable Costs (b) | 5,524 | 3,614 | 3,317 | 676 | 433 | 13,564 | ||||||||||||||||||||||||||||||||
| Fixed Costs and other (c) | 3,113 | 1,802 | 803 | 960 | 717 | 7,395 | ||||||||||||||||||||||||||||||||
| Depreciation and amortization (d) | 1,423 | 640 | 633 | 33 | 96 | 2,825 | ||||||||||||||||||||||||||||||||
| Operating Profit (e) | 4,244 | 2,486 | 1,806 | 491 | 43 | 9,070 | ||||||||||||||||||||||||||||||||
| Expenditures for long-lived assets | $ | 2,999 | $ | 635 | $ | 975 | $ | 24 | $ | 107 | $ | 4,740 | ||||||||||||||||||||||||||
| (Millions of dollars) | 2025 | 2024 | 2023 | |||||||||||||||||
| Total segment depreciation and amortization | $ | 2,986 | $ | 2,857 | $ | 2,825 | ||||||||||||||
| Purchase accounting impacts - Linde AG (a) | 777 | 923 | 991 | |||||||||||||||||
| Total depreciation and amortization | $ | 3,763 | $ | 3,780 | $ | 3,816 | ||||||||||||||
| (Millions of dollars) | 2025 | 2024 | 2023 | |||||||||||||||||
| Total segment operating profit | $ | 10,137 | $ | 9,720 | $ | 9,070 | ||||||||||||||
| Cost reduction program and other charges | 273 | 145 | 40 | |||||||||||||||||
| Purchase accounting impacts - Linde AG (a) | 941 | 940 | 1,006 | |||||||||||||||||
| Interest expense - net | 255 | 256 | 200 | |||||||||||||||||
| Net pension and OPEB cost (benefit), excluding service cost | (229) | (190) | (164) | |||||||||||||||||
| Total consolidated income before income taxes and equity investments | $ | 8,897 | $ | 8,569 | $ | 7,988 | ||||||||||||||
| (Millions of dollars) | 2025 | 2024 | 2023 | |||||||||||||||||
| United States | $ | 12,182 | $ | 11,497 | $ | 10,566 | ||||||||||||||
| China | 2,600 | 2,649 | 2,585 | |||||||||||||||||
| Germany (a) | 2,432 | 2,509 | 2,827 | |||||||||||||||||
| United Kingdom | 1,510 | 1,540 | 1,507 | |||||||||||||||||
| Australia | 1,287 | 1,354 | 1,303 | |||||||||||||||||
| Mexico | 1,391 | 1,346 | 1,292 | |||||||||||||||||
| Brazil | 1,325 | 1,263 | 1,302 | |||||||||||||||||
| Other – non-U.S. | 11,259 | 10,847 | 11,472 | |||||||||||||||||
| Total Sales | $ | 33,986 | $ | 33,005 | $ | 32,854 | ||||||||||||||
| (Millions of dollars) | 2025 | 2024 | 2023 | |||||||||||||||||
| United States | $ | 11,229 | $ | 9,663 | $ | 8,490 | ||||||||||||||
| China | 2,129 | 2,022 | 2,063 | |||||||||||||||||
| Germany | 1,550 | 1,386 | 1,584 | |||||||||||||||||
| Brazil | 896 | 738 | 836 | |||||||||||||||||
| Mexico | 852 | 704 | 768 | |||||||||||||||||
| United Kingdom | 718 | 668 | 684 | |||||||||||||||||
| Australia | 621 | 573 | 654 | |||||||||||||||||
| Other – non-U.S. | 10,265 | 9,021 | 9,473 | |||||||||||||||||
| Total long-lived assets (a) | $ | 28,260 | $ | 24,775 | $ | 24,552 | ||||||||||||||
| (Millions of dollars) | Year Ended December 31, 2025 | ||||||||||||||||||||||
| Sales | Americas | EMEA | APAC | Engineering | Other | Total | % | ||||||||||||||||
| Merchant | $ | 4,892 | $ | 2,860 | $ | 2,213 | $ | — | $ | 194 | $ | 10,159 | 30 | % | |||||||||
| On-Site | 3,609 | 1,685 | 2,789 | — | — | 8,083 | 24 | % | |||||||||||||||
| Packaged Gas | 6,460 | 3,970 | 1,398 | — | 25 | 11,853 | 35 | % | |||||||||||||||
| Other | 247 | 34 | 261 | 2,250 | 1,099 | 3,891 | 11 | % | |||||||||||||||
| $ | 15,208 | $ | 8,549 | $ | 6,661 | $ | 2,250 | $ | 1,318 | $ | 33,986 | 100 | % | ||||||||||
| (Millions of dollars) | Year Ended December 31, 2024 | ||||||||||||||||||||||
| Sales | Americas | EMEA | APAC | Engineering | Other | Total | % | ||||||||||||||||
| Merchant | $ | 4,572 | $ | 2,765 | $ | 2,233 | $ | — | $ | 208 | $ | 9,778 | 30 | % | |||||||||
| On-Site | 3,239 | 1,722 | 2,695 | — | — | 7,656 | 23 | % | |||||||||||||||
| Packaged Gas | 6,414 | 3,805 | 1,376 | — | 28 | 11,623 | 35 | % | |||||||||||||||
| Other | 217 | 60 | 328 | 2,322 | 1,021 | 3,948 | 12 | % | |||||||||||||||
| $ | 14,442 | $ | 8,352 | $ | 6,632 | $ | 2,322 | $ | 1,257 | $ | 33,005 | 100 | % | ||||||||||
| (Millions of dollars) | Year Ended December 31, 2023 | ||||||||||||||||||||||
| Sales | Americas | EMEA | APAC | Engineering | Other | Total | % | ||||||||||||||||
| Merchant | $ | 4,370 | $ | 2,773 | $ | 2,242 | $ | — | $ | 218 | $ | 9,603 | 29 | % | |||||||||
| On-Site | 3,246 | 1,980 | 2,599 | — | — | 7,825 | 24 | % | |||||||||||||||
| Packaged Gas | 6,457 | 3,735 | 1,416 | — | 46 | 11,654 | 35 | % | |||||||||||||||
| Other | 231 | 54 | 302 | 2,160 | 1,025 | 3,772 | 12 | % | |||||||||||||||
| $ | 14,304 | $ | 8,542 | $ | 6,559 | $ | 2,160 | $ | 1,289 | $ | 32,854 | 100 | % | ||||||||||
| Plan Category | Number of securities to be issued upon exercise of outstanding options, warrants and rights (a) | Weighted-average exercise price of outstanding options, warrants and rights (b) | Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in column (a)) (c) | |||||||||||||||||
| Equity compensation plans approved by shareholders | 5,563,811 | (1) | $ | 233.38 | 6,496,096 | (2) | ||||||||||||||
| Equity compensation plans not approved by shareholders | — | — | — | |||||||||||||||||
| Total | 5,563,811 | $ | 233.38 | 6,496,096 | ||||||||||||||||
| Exhibit No. | Description | |||||||
| 2.1 | ||||||||
| 2.1a | ||||||||
| **2.2 | ||||||||
| **2.3 | ||||||||
| **2.3a | ||||||||
| **2.3b | ||||||||
| **2.3c | ||||||||
| 3.01 | ||||||||
| 4.01 | ||||||||
| Exhibit No. | Description | |||||||
| 4.02 | ||||||||
| 4.03 | ||||||||
| 4.04 | ||||||||
| 4.05 | ||||||||
| 4.06 | ||||||||
| 4.07 | ||||||||
| 4.08 | ||||||||
| 4.09 | ||||||||
| 4.10 | ||||||||
| 4.11 | ||||||||
| 4.12 | ||||||||
| 4.13 | ||||||||
| 4.14 | ||||||||
| 4.15 | ||||||||
| 4.16 | ||||||||
| Exhibit No. | Description | |||||||
| 4.17 | ||||||||
| 4.18 | ||||||||
| 4.19 | ||||||||
| 4.20 | ||||||||
| 4.21 | ||||||||
| 4.22 | ||||||||
| 4.23 | Copies of the agreements related to long-term debt which are not required to be filed as exhibits to this Annual Report on Form 10-K will be furnished to the Securities and Exchange Commission upon request. | |||||||
| *10 | ||||||||
| 10.01 | ||||||||
| 10.02 | ||||||||
| *10.03 | ||||||||
| *10.03a | ||||||||
| *10.03b | ||||||||
| *10.03c | ||||||||
| *10.03d | ||||||||
| *10.03e | ||||||||
| *10.04 | ||||||||
| Exhibit No. | Description | |||||||
| *10.05 | ||||||||
| *10.05a | ||||||||
| *10.05b | ||||||||
| *10.05c | ||||||||
| *10.05d | ||||||||
| *10.05e | ||||||||
| *10.05f | ||||||||
| *10.05g | ||||||||
| *10.05h | ||||||||
| *10.06 | ||||||||
| *10.06a | ||||||||
| *10.06b | ||||||||
| *10.06c | ||||||||
| *10.06d | ||||||||
| *10.06e | ||||||||
| *10.06f | ||||||||
| *10.07 | ||||||||
| *10.08 | ||||||||
| Exhibit No. | Description | |||||||
| *10.08b | ||||||||
| *10.09 | ||||||||
| *10.10 | ||||||||
| *10.10a | ||||||||
| *10.10b | ||||||||
| *10.10c | ||||||||
| *10.10d | ||||||||
| *10.10e | ||||||||
| *10.10f | ||||||||
| *10.10g | ||||||||
| *10.10h | ||||||||
| *10.10i | ||||||||
| *10.10j | ||||||||
| *10.10k | ||||||||
| *10.10l | ||||||||
| *10.10m | ||||||||
| *10.11 | ||||||||
| 10.12 | ||||||||
| Exhibit No. | Description | |||||||
| 10.13 | ||||||||
| *10.14 | ||||||||
| *10.15 | ||||||||
| *10.16 | ||||||||
| 19.01 | ||||||||
| 21.01 | ||||||||
| 23.01 | ||||||||
| 31.01 | ||||||||
| 31.02 | ||||||||
| 32.01 | ||||||||
| 32.02 | ||||||||
| 97.1 | ||||||||
| 101.INS | XBRL Instance Document: The XBRL Instance Document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. | |||||||
| 101.SCH | XBRL Taxonomy Extension Schema | |||||||
| 101.CAL | XBRL Taxonomy Extension Calculation Linkbase | |||||||
| 101.LAB | XBRL Taxonomy Extension Label Linkbase | |||||||
| 101.PRE | XBRL Taxonomy Extension Presentation Linkbase | |||||||
| 101.DEF | XBRL Taxonomy Extension Definition Linkbase | |||||||
| * | Indicates a management contract or compensatory plan or arrangement. | ||||
| ** | Certain schedules or similar attachments have been omitted pursuant to Item 601(b)(2) of Regulation S-K. The Registrant agrees to furnish supplemental copies of any of the omitted schedules or attachments upon request by the SEC. | ||||
| Linde plc | ||||||||||||||||||||
| (Registrant) | ||||||||||||||||||||
| Date: February 25, 2026 | By: | /s/ KELCEY E. HOYT | ||||||||||||||||||
Kelcey E. Hoyt Chief Accounting Officer | ||||||||||||||||||||
| /s/ SANJIV LAMBA | /s/ MATTHEW J. WHITE | /s/ PROF. DDR. ANN-KRISTIN ACHLIETNER | ||||||||||||
Sanjiv Lamba Chairman and Chief Executive Officer | Matthew J. White Chief Financial Officer | Ann-Kristin Achleitner Director | ||||||||||||
| /s/ ROBERT L. WOOD | /s/ DR. THOMAS ENDERS | /s/ JOSEF KAESER | ||||||||||||
Robert L. Wood Director | Thomas Enders Director | Josef Kaeser Director | ||||||||||||
| /s/ DR. VICTORIA OSSADNIK | /s/ ALBERTO WEISSER | /s/ PAULA REYNOLDS | ||||||||||||
Victoria Ossadnik Director | Alberto Weisser Director | Paula Reynolds Director | ||||||||||||
| /s/ HUGH GRANT | ||||||||||||||
Hugh Grant Director | ||||||||||||||
By: /s/ David P. Strauss | ||
| David Strauss | ||
| Executive Vice President & Chief Human Resources Officer | ||
Date: March 13, 2024 | ||
| Linde plc Subsidiaries | Place of Incorporation | ||||
| 10 Riverview Drive LLC | Delaware | ||||
| AB Held | Sweden | ||||
| AFRICAN OXYGEN (PTY) LTD | South Africa | ||||
| AFRICAN WELDING COMPANY (Pty) Ltd | South Africa | ||||
| AFROX - África Oxigénio, Limitada | Angola | ||||
| AFROX (LESOTHO) (PTY) LTD | Lesotho | ||||
| AFROX (PROPRIETARY) LIMITED | South Africa | ||||
| AFROX AFRICAN INVESTMENTS (PTY) LIMITED | South Africa | ||||
| AFROX ESWATINI (PROPRIETARY) LIMITED | Eswatini | ||||
| AFROX GAS & ENGINEERING SUPPLIES (BOTSWANA) (PTY) LIMITED | Botswana | ||||
| AFROX INTERNATIONAL LIMITED | Mauritius | ||||
| Afrox Malawi Limited | Malawi | ||||
| Afrox Moçambique, Limitada | Mozambique | ||||
| AFROX PROPERTIES (PTY) LIMITED | South Africa | ||||
| AFROX ZAMBIA LIMITED | Zambia | ||||
| Agatronic AB | Sweden | ||||
| Agua y Gas de Sillunchi S.A. | Ecuador | ||||
| AHP Alliance of Columbia | South Carolina | ||||
| AHP Delmarva, LLP | Maryland | ||||
| AHP Home Care Alliance of Gainesville | Florida | ||||
| AHP Home Care Alliance of Tennessee | Tennessee | ||||
| AHP Home Care Alliance of Virginia | Virginia | ||||
| AHP Home Medical Equipment Partnership of Texas | Texas | ||||
| AHP Knoxville Partnership | Tennessee | ||||
| AHP-MHR Home Care, LLP | Nebraska | ||||
| AIRCO PROPERTIES INC | Delaware | ||||
| ALBOC (JERSEY) LIMITED | Jersey | ||||
| ALPHA RESPIRATORY INC. | Delaware | ||||
| AMALGAMATED GAS AND WELDING (PTY) LIMITED | South Africa | ||||
| AMALGAMATED WELDING AND CUTTING HOLDINGS (PROPRIETARY) LIMITED | South Africa | ||||
| American HomePatient Arkansas Ventures, Inc. | Delaware | ||||
| American HomePatient of Kingstree, LLC | South Carolina | ||||
| American HomePatient of New York, Inc. | New York | ||||
| American HomePatient of Sanford, LLC | North Carolina | ||||
| American HomePatient of Texas, LLC | Texas | ||||
| American HomePatient of Unifour, LLC | North Carolina | ||||
| American HomePatient Tennessee Ventures, Inc. | Delaware | ||||
| American HomePatient Ventures, Inc. | Tennessee | ||||
| AMERICAN HOMEPATIENT, INC. | Delaware | ||||
| American HomePatient, Inc. (f/k/a AHP NV Corp.) | Nevada | ||||
| Anhui JuLan Industrial Gases Co., Ltd. | China | ||||
| AS Linde Gas | Estonia | ||||
| ASIA UNION ELECTRONIC CHEMICALS - RENO, INC. | Nevada | ||||
| AUECC Shanghai (Baoshan) Co. Ltd. | China | ||||
| AUECC Shanghai (Fengxian) Co. Ltd. | China | ||||
| Augusta Company Limited | Thailand | ||||
| AUSCOM HOLDINGS PTY LIMITED | New South Wales | ||||
| AWCE (PROPRIETARY) LIMITED | South Africa | ||||
| B.V. Nederlandse Pijpleidingmaatschappij | Netherlands | ||||
| Baptist Ventures - AHP Homecare Alliance of Montgomery | Alabama | ||||
| Beijing Praxair, Inc. | China | ||||
| Blue Ridge Home Care | North Carolina | ||||
| BOC (PHILS.) HOLDINGS, INC. | Philippines | ||||
| BOC (TRADING) LIMITED | Ireland | ||||
| BOC AIP Limited Partnership | New South Wales | ||||
| BOC Australia Pty Limited | New South Wales | ||||
| BOC AUSTRALIAN FINANCE LIMITED | Jersey | ||||
| BOC CHILE HOLDINGS LIMITED | England | ||||
| BOC de Chile S.A. | Chile | ||||
| BOC DISTRIBUTION SERVICES LIMITED | England | ||||
| BOC Europe Holdings B.V. | Netherlands | ||||
| BOC GASES ARUBA N.V. | Aruba | ||||
| BOC GASES FINANCE LIMITED | New South Wales | ||||
| BOC GASES IRELAND HOLDINGS LIMITED | Ireland | ||||
| BOC Gases Ireland Limited | Ireland | ||||
| BOC GASES LIMITED | England | ||||
| BOC GASES MOZAMBIQUE LIMITED | Mozambique | ||||
| BOC GASES SOLOMON ISLANDS LIMITED | Solomon Islands | ||||
| BOC GIST INC | Philippines | ||||
| BOC GROUP PTY LIMITED | New South Wales | ||||
| BOC HEALTHCARE LIMITED | England | ||||
| BOC HELEX | England | ||||
| BOC HOLDINGS | England | ||||
| BOC Intressenter AB | Sweden | ||||
| BOC INVESTMENT HOLDING COMPANY (IRELAND) LIMITED | Ireland | ||||
| BOC INVESTMENT HOLDINGS LIMITED | England | ||||
| BOC Investments Ireland Unlimited Company | Ireland | ||||
| BOC INVESTMENTS NO.1 LIMITED | England | ||||
| BOC INVESTMENTS NO.5 | England | ||||
| BOC Kenya plc | Kenya | ||||
| BOC KOREA HOLDINGS LIMITED | England | ||||
| BOC LIENHWA (BVI) HOLDING Co., Ltd. | British Virgin Islands | ||||
| BOC LIMITED | England | ||||
| BOC Limited (Australia) | New South Wales | ||||
| BOC LIMITED (New Zealand) | New Zealand | ||||
| BOC NETHERLANDS HOLDINGS LIMITED | England | ||||
| BOC NEW ZEALAND HOLDINGS LIMITED | New Zealand | ||||
| BOC NOMINEES LIMITED | England | ||||
| BOC Papua New Guinea Limited | Papua New Guinea | ||||
| BOC PENSION SCHEME TRUSTEES LIMITED | England | ||||
| BOC PENSIONS LIMITED | England | ||||
| BOC PREFERENCE LIMITED | Jersey | ||||
| BOC RETIREMENT BENEFITS SCHEME TRUSTEES LIMITED | England | ||||
| BOC Tanzania Limited | Tanzania, the United Republic of | ||||
| BOC Uganda Limited | Uganda | ||||
| BOCLH Industrial Gases (Chengdu) Co., Ltd | China | ||||
| BOCLH Industrial Gases (DaLian) Co., Ltd. | China | ||||
| BOCLH Industrial Gases (Shanghai) Co., Ltd. | China | ||||
| BOCLH Industrial Gases (Songjiang) Co., Ltd. | China | ||||
| BOCLH Industrial Gases (Suzhou) Co., Ltd. | China | ||||
| BOCLH Industrial Gases (Waigaoqiao) Co., Ltd. (aka CONFEDERATE TRADING (SHANGHAI) COMPANY LIMITED) | China | ||||
| BOCLH Industrial Gases (Xiamen) Co., Ltd. | China | ||||
| BOGGY CREEK PTY LIMITED | New South Wales | ||||
| BOTSWANA OXYGEN COMPANY (PTY) LIMITED | Botswana | ||||
| BOTSWANA STEEL ENGINEERING (PTY) LIMITED | Botswana | ||||
| BRITISH INDUSTRIAL GASES LIMITED | England | ||||
| BRITISH OXYGEN (HONG KONG) LIMITED | Hong Kong | ||||
| Cap2U GmbH | Germany | ||||
| CARING RESPONDERS LLC | Delaware | ||||
| Catholic Health Home Respiratory, LLC | New York | ||||
| Ceylon Oxygen Ltd. | Sri Lanka | ||||
| CIGC CORPORATION | Philippines | ||||
| Coastal Home Care | South Carolina | ||||
| Commercium Immobilien- und Beteiligungs-GmbH | Germany | ||||
| Compañía de Nitrógeno de Cantarell, S.A. de C.V. | Mexico | ||||
| Comprehensive Sleep Solutions, LLC | Arizona | ||||
| CONVACARE SERVICES, INC. | Indiana | ||||
| COOPER CRYOSERVICE LIMITED | Ireland | ||||
| CPAP SUPPLY USA LLC | Delaware | ||||
| CRYO INDUSTRIAL GASES, INC. | Philippines | ||||
| Cryostar Cryogenic Equipments (Hangzhou) Co. Ltd. | China | ||||
| Cryostar do Brasil Equipamentos Rotativos & Criogenicos Ltda. | Brazil | ||||
| CRYOSTAR LIMITED | England | ||||
| CRYOSTAR SAS | France | ||||
| Cryostar Singapore Pte Ltd | Singapore | ||||
| Cryostar USA LLC | Delaware | ||||
| Dablioeme Participacoes Societarias Ltda. | Brazil | ||||
| DAVAO OXYGEN CORPORATION | Philippines | ||||
| DEMOX COMÉRCIO E DISTRIBUIÇÃO DE OXIGÊNIO LTDA. | Brazil | ||||
| Designated Companies, Inc. | New York | ||||
| Distribuciones Invegas S.C.A. | Venezuela | ||||
| DME Supply USA, LLC | Delaware | ||||
| EFFECTECH LIMITED | England & Wales | ||||
| EHVIL DISSENTIENTS LIMITED | England | ||||
| ELGAS LIMITED | New South Wales | ||||
| ELGAS RETICULATION PTY LIMITED | New South Wales | ||||
| Eurogaz-Gdynia Sp. z o.o. | Poland | ||||
| Famex Comercio Atacadista de Gas Carbonico Ltda. | Brazil | ||||
| FLUOROGAS LIMITED | England | ||||
| Food Service Logistics Limited | England & Wales | ||||
| FOOD SERVICE LOGISTICS LLC | Delaware | ||||
| Founders Healthcare L.L.C. | Arizona | ||||
| FUTURE INDUSTRIAL AND WELDING SUPPLIES LTD. | England | ||||
| Fuzhou Linde Lienhwa Gases Co., Ltd | China | ||||
| G.L BAKER (TRANSPORT) LIMITED | England | ||||
| GAFFNEY INDUSTRIAL & WELDING SUPPLIES LTD | England | ||||
| Gama Gases Especiais Ltda. | Brazil | ||||
| GAS & GEAR LIMITED | England | ||||
| Gases de Ensenada S.A. | Argentina | ||||
| Gases Tachira S.A. (In Liquidation) | Venezuela | ||||
| GER Linde GmbH | Germany | ||||
| GI/LINDE ALGERIE SPA | Algeria | ||||
| GNL Gemini Comercializacao e Logistica de Gas Ltda. | Brazil | ||||
| GRANDPLAINS PROPERTIES, INC. | Philippines | ||||
| Great Lakes Street, Inc. | Delaware | ||||
| Guangdong Shaogang Linde Gas Co., Ltd. | China | ||||
| HANDIGAS (BOTSWANA) (PTY) LIMITED | Botswana | ||||
| HANDIGAS LIMITED | England | ||||
| HANDIGAS SWAZILAND (PTY) LIMITED | Eswatini | ||||
| HEALTH CARE SOLUTIONS AT HOME INC. | Delaware | ||||
| HEAT GAS (PTY) LIMITED | Botswana | ||||
| HICK, HARGREAVES AND COMPANY LIMITED | England | ||||
| HKO DEVELOPMENT COMPANY LIMITED | Hong Kong | ||||
| Holox Inc. | Georgia | ||||
| HOME-CARE EQUIPMENT NETWORK INC. | Delaware | ||||
| Homelink Home Health Care | Arkansas | ||||
| Hydromotive GmbH & Co. KG | Germany | ||||
| Hydromotive Verwaltungs-GmbH | Germany | ||||
| IGL (PTY) LIMITED | Namibia | ||||
| IGL PROPERTIES (PTY) LIMITED | Namibia | ||||
| INDONESIA POWER HOLDINGS LIMITED | England | ||||
| Industria Paraguaya de Gases S.R.L. | Paraguay | ||||
| Industria Venezolana de Gas INVEGAS, S.C.A. | Venezuela | ||||
| INDUSTRIAL & WELDING SUPPLIES (NORTH WEST) LTD | England | ||||
| INDUSTRIAL SUPPLIES & SERVICES LIMITED | England | ||||
| INVERTONE LIMITED | England & Wales | ||||
| ISAS TRUST | South Africa | ||||
| IWS (INDUSTRIAL & WELDING SUPPLIES) LIMITED | England | ||||
| Jianyang Linde Medical Gases Company Limited | China | ||||
| Kelvin Finance Company Limited | Ireland | ||||
| Kepler 7B Insurance Company Inc. | Connecticut | ||||
| KIDDO INVESTMENTS (PTY) LIMITED | Botswana | ||||
| Kiinteistö Oy Karakaasu | Finland | ||||
| Kiinteistö Oy Karaportti | Finland | ||||
| Kosmoid Finance Unlimited Company | Ireland | ||||
| KTPV (THAILAND) LIMITED | Thailand | ||||
| LANSING GROUP LIMITED | England | ||||
| LEEN GATE INDUSTRIAL & WELDING SUPPLIES (SCOTLAND) LIMITED | England | ||||
| LEENGATE INDUSTRIAL & WELDING SUPPLIES (NORTH EAST) LTD | England | ||||
| LEENGATE INDUSTRIAL & WELDING SUPPLIES LTD | England | ||||
| LESOTHO OXYGEN COMPANY (PTY) LIMITED | Lesotho | ||||
| Lien Hwa Industrial HK Limited | Hong Kong | ||||
| LINCARE HOLDINGS INC. | Delaware | ||||
| LINCARE INC. | Delaware | ||||
| LINCARE LICENSING INC. | Delaware | ||||
| LINCARE OF CANADA ACQUISITIONS INC. | Delaware | ||||
| LINCARE OF CANADA INC. | Ontario | ||||
| LINCARE PHARMACY SERVICES INC. | Delaware | ||||
| LINCARE PROCUREMENT INC. | Delaware | ||||
| LINCARE PULMONARY REHAB MANAGEMENT, LLC | Delaware | ||||
| Lincare Pulmonary Rehab Services of Missouri, LLC | Missouri | ||||
| LINCARE PULMONARY REHAB SERVICES OF OHIO, LLC | Ohio | ||||
| Linde (Australia) Pty. Ltd. | New South Wales | ||||
| Linde (Beijing) Semiconductor Gas Co., Ltd. | China | ||||
| Linde (China) Investment Co., Ltd. | China | ||||
| Linde (Hefei) Industrial Gas Co., Ltd. | China | ||||
| Linde (Huizhou) Industrial Gas Co., Ltd. | China | ||||
| Linde (Quanzhou) Carbon Dioxide Co. Ltd. | China | ||||
| Linde (Shanghai) Electronic Gas Co., Ltd. | China | ||||
| Linde (Shanghai) Industrial Gas Co., Ltd. | China | ||||
| Linde (Shanghai) Semiconductor Gas Co., Ltd. | China | ||||
| Linde (Shanghai) Specialty Gas Co., Ltd. | China | ||||
| Linde (Thailand) Public Company Limited | Thailand | ||||
| Linde Advanced Material Technologies Inc. | Delaware | ||||
| Linde AMT Chonan Co., Ltd. | Korea (the Republic of) | ||||
| Linde AMT GmbH | Germany | ||||
| Linde AMT Italy S.r.l. | Italy | ||||
| Linde AMT Japan K.K. | Japan | ||||
| Linde AMT Mercus SAS | France | ||||
| Linde AMT Schluechtern GmbH | Germany | ||||
| Linde AMT Singapore Pte. Ltd. | Singapore | ||||
| Linde AMT St-Etienne S.A.S. | France | ||||
| Linde AMT Toulouse SAS | France | ||||
| LINDE AMT UK LIMITED | England | ||||
| Linde Arabian Contracting Co., Ltd. | Saudi Arabia | ||||
| Linde Bangladesh Limited | Bangladesh | ||||
| Linde Bolivia SRL | Bolivia (Plurinational State of) | ||||
| LINDE BUSINESS SOLUTIONS CENTER PHILIPPINES, INC. | Philippines | ||||
| LINDE CANADA HOLDINGS LIMITED | England | ||||
| Linde Canada Inc. | Canada | ||||
| LINDE CANADA INVESTMENTS LIMITED | England & Wales | ||||
| Linde Carbon Dioxide (Nanjing) Gas Co., Ltd. | China | ||||
| Linde Carbonic Company Ltd., Shanghai | China | ||||
| LINDE CRYOGENICS LIMITED | England | ||||
| Linde Ecuador S.A. | Ecuador | ||||
| LINDE ELECTRONICS | France | ||||
| Linde Electronics & Specialty Gases (Suzhou) Co Ltd. | China | ||||
| Linde Electronics B.V. | Netherlands | ||||
| Linde Electronics GmbH | Austria | ||||
| Linde Electronics GmbH & Co. KG | Germany | ||||
| Linde Electronics Verwaltungs GmbH | Germany | ||||
| LINDE ELECTRONICS, S.L. | Spain | ||||
| Linde Engineering (Dalian) Co. Ltd. | China | ||||
| Linde Engineering (Malaysia) Sdn. Bhd. | Malaysia | ||||
| Linde Engineering APAC Co., Ltd. | China | ||||
| LINDE ENGINEERING AUSTRALIA PTY LTD | New South Wales | ||||
| Linde Engineering India Private Limited | India | ||||
| Linde Engineering Korea Ltd. | Korea (the Republic of) | ||||
| Linde Engineering Middle East LLC | United Arab Emirates | ||||
| Linde Engineering North America LLC (a.k.a. Linde Engineering Americas) | Delaware | ||||
| Linde Engineering South Africa (Pty) Ltd. | South Africa | ||||
| Linde Engineering US LLC | Delaware | ||||
| Linde Enterprises (West) Private Limited | India | ||||
| Linde EOX Sdn. Bhd. | Malaysia | ||||
| Linde Euro Finance UK Limited | England & Wales | ||||
| LINDE FINANCE | England | ||||
| Linde Finance B.V. | Netherlands | ||||
| Linde Finance UK Limited | England & Wales | ||||
| LINDE FRANCE | France | ||||
| LINDE GAS & EQUIPMENT INC. | Delaware | ||||
| Linde Gas (Anhui) Co., Ltd. | China | ||||
| Linde Gas (Guangxi) Co., Ltd. | China | ||||
| Linde Gas (Guangzhou) Co., Ltd. | China | ||||
| Linde Gas (H.K.) Limited | Hong Kong | ||||
| Linde Gas (Hainan) Co., Ltd. | China | ||||
| Linde Gas (Jiangxi) Co., Ltd. | China | ||||
| Linde Gas (Jiaxing) Co., Ltd. | China | ||||
| Linde Gas (Jining) Co., Ltd. | China | ||||
| Linde Gas (Qingdao) Co., Ltd. | China | ||||
| Linde Gas (Tianjin) Co., Ltd. | China | ||||
| Linde Gas (Tongling) Co., Ltd. | China | ||||
| Linde Gas (Wuhan) Co., Ltd. | China | ||||
| Linde Gas (Yangzhou) Co., Ltd. | China | ||||
| Linde Gas (Zhengzhou) Co.,Ltd | China | ||||
| Linde Gas (Zhenjiang) Co., Ltd. | China | ||||
| Linde Gas a.s. | Czech Republic | ||||
| Linde Gas A/S | Denmark | ||||
| Linde Gas AB | Sweden | ||||
| Linde Gas Algerie S.p.A. | Algeria | ||||
| LINDE GAS AS | Norway | ||||
| Linde Gas Asia Pte Ltd | Singapore | ||||
| Linde Gas Belgium NV | Belgium | ||||
| Linde Gas Benelux B.V. | Netherlands | ||||
| Linde Gas Bulgaria EOOD | Bulgaria | ||||
| Linde Gas Chile S.A. | Chile | ||||
| Linde Gas Cryoservices B.V. | Netherlands | ||||
| Linde Gas Curaçao N.V. | Curaçao | ||||
| LINDE GAS DOMINICANA, S.R.L. | Dominican Republic | ||||
| Linde Gas ehf. | Iceland | ||||
| LINDE GAS ESPAÑA SOCIEDAD ANONIMA | Spain | ||||
| Linde Gas GmbH | Austria | ||||
| LINDE GAS HOLDINGS LIMITED | England | ||||
| Linde Gas Italia S.r.l. | Italy | ||||
| LINDE GAS MIDDLE EAST LLC | United Arab Emirates | ||||
| Linde Gas Ningbo Ltd. | China | ||||
| Linde Gas Products Malaysia Sdn. Bhd. | Malaysia | ||||
| Linde Gas Produktionsgesellschaft mbH & Co. KG | Germany | ||||
| Linde Gas s. r. o. | Slovakia | ||||
| Linde Gas Schweiz AG | Switzerland | ||||
| Linde Gas SIA | Latvia | ||||
| Linde Gas Singapore Pte. Ltd. | Singapore | ||||
| Linde Gas Southeast (Xiamen) Ltd. | China | ||||
| LINDE GAS SRBIJA Industrija gasova a.d. Bečej | Serbia | ||||
| Linde Gas Therapeutics Benelux B.V. | Netherlands | ||||
| Linde Gas Therapeutics GmbH | Germany | ||||
| Linde Gas Tunisie S.A. | Tunisia | ||||
| Linde Gas UAB | Lithuania | ||||
| Linde Gas Verwaltungs GmbH | Germany | ||||
| Linde Gas Vietnam Limited | Vietnam | ||||
| Linde Gas Xiamen Ltd. | China | ||||
| Linde Gas Zhenhai Ltd. | China | ||||
| Linde Gases (Changzhou) Company Limited | China | ||||
| Linde Gases (Chengdu) Co., Ltd. | China | ||||
| Linde Gases (Hefei) Co., Ltd. | China | ||||
| Linde Gases (Langfang) Co., Ltd. | China | ||||
| Linde Gases (Meishan) Co., Ltd. | China | ||||
| Linde Gases (Nanjing) Company Limited | China | ||||
| Linde Gases (Shanghai) Co., Ltd. | China | ||||
| Linde Gases (Suzhou) Company Limited | China | ||||
| Linde Gases (Taixing) Co., Ltd. | China | ||||
| Linde Gases (Xuzhou) Company Limited | China | ||||
| Linde Gases (Yantai) Co., Ltd. | China | ||||
| Linde Gases (Zhangzhou) Co., Ltd. | China | ||||
| Linde Gases Daxie Company Limited | China | ||||
| Linde Gases Moçambique, Limitada | Mozambique | ||||
| Linde Gaz Anonim Şirketi | Turkey | ||||
| Linde Gáz Magyarország Zrt. | Hungary | ||||
| LINDE GAZ POLSKA Spółka z o.o. | Poland | ||||
| LINDE GAZ ROMANIA S.R.L. | Romania | ||||
| Linde Global IT Services s. r. o. | Slovakia | ||||
| LINDE GLOBAL SERVICES PHILIPPINES, INC. | Philippines | ||||
| LINDE GLOBAL SERVICES PORTUGAL, UNIPESSOAL LDA | Portugal | ||||
| LINDE GLOBAL SERVICES ROMANIA S.R.L. | Romania | ||||
| Linde Global Support Services Private Limited | India | ||||
| Linde GmbH | Germany | ||||
| Linde Gulf Industrial Gases LLC | Oman | ||||
| Linde H2 Energy Co., Ltd. | Korea (the Republic of) | ||||
| LINDE HADJIKYRIAKOS GAS LIMITED | Cyprus | ||||
| Linde Healthcare AB | Sweden | ||||
| Linde Healthcare España, S.L. Unipersonal | Spain | ||||
| LINDE HELIUM HOLDINGS LIMITED | England | ||||
| LINDE HELIUM M E FZCO | United Arab Emirates | ||||
| Linde Hellas Monoprosopi E.P.E. | Greece | ||||
| Linde Hidrógeno, S.A. de C.V. | Mexico | ||||
| Linde HKO Limited | Hong Kong | ||||
| Linde Holding GmbH | Germany | ||||
| Linde Holdings Netherlands B.V. | Netherlands | ||||
| Linde Holdings Netherlands No.3 B.V. | Netherlands | ||||
| Linde Holdings New Zealand Limited | New Zealand | ||||
| Linde Holdings SAS | France | ||||
| Linde Holdings, LLC | Delaware | ||||
| LINDE HOMECARE FRANCE | France | ||||
| Linde Huachang (Zhangjiagang) Gas Co. Ltd. | China | ||||
| Linde HyCO Limited | Thailand | ||||
| LINDE HYDROGEN FUELTECH (DALIAN) CO.,LTD. | China | ||||
| Linde Hydrogen FuelTech GmbH | Austria | ||||
| Linde Inc. | Delaware | ||||
| LINDE INDIA LIMITED | India | ||||
| LINDE INDUSTRIAL GASES (MALAYSIA) SDN. BHD. | Malaysia | ||||
| Linde Inversiones S.R.L. | Peru | ||||
| LINDE INVESTMENTS FINLAND OY | Finland | ||||
| LINDE INVESTMENTS LLC | Delaware | ||||
| LINDE INVESTMENTS No.1 LIMITED | England | ||||
| Linde Jubail Industrial Gases Factory LLC | Saudi Arabia | ||||
| Linde Korea Co., Ltd. | Korea (the Republic of) | ||||
| Linde Kryotechnik AG | Switzerland | ||||
| Linde Lienhwa China Holding Co., Ltd. | China | ||||
| Linde Lienhwa Gases (BeiJing) Co., Ltd. | China | ||||
| Linde Lienhwa Gases (Chengdu) Co., Ltd. | China | ||||
| Linde Lienhwa Gases (Shanghai) Co., Ltd. | China | ||||
| Linde Lienhwa Gases (Wuhan) Co., Ltd | China | ||||
| Linde Lienhwa Industrial Gases (Beijing) Co., Ltd. | China | ||||
| Linde Lienhwa Industrial Gases (Xianyang) Co., Ltd. | China | ||||
| LINDE MALAYSIA HOLDINGS BERHAD | Malaysia | ||||
| LINDE MALAYSIA SDN. BHD. | Malaysia | ||||
| Linde Médica, S.L. | Spain | ||||
| LINDE MEDICAL SERVICES MIDDLE EAST LLC | United Arab Emirates | ||||
| LINDE MEDICALE Srl | Italy | ||||
| LINDE MEDICINAL, S.L. | Spain | ||||
| Linde Meishan (Nanjing) Gas Co., Ltd. | China | ||||
| Linde Nanjing Chemical Industrial Park Gases Co., Ltd. | China | ||||
| LINDE NORTH AMERICA HOLDINGS LIMITED | England | ||||
| LINDE O&M ISRAEL LTD | Israel | ||||
| Linde Österreich Holding GmbH | Austria | ||||
| LINDE PERU S.R.L. | Peru | ||||
| LINDE PHILIPPINES (SOUTH), INC. | Philippines | ||||
| LINDE PHILIPPINES, INC. | Philippines | ||||
| LINDE PORTUGAL, LDA | Portugal | ||||
| Linde Process Plants Canada Inc. | Canada | ||||
| Linde Puerto Rico B.V. | Netherlands | ||||
| Linde Qiangsheng Gases (Nanjing) Co., Ltd. | China | ||||
| Linde Regional Headquarters Company | Kingdom of Saudi Arabia | ||||
| LINDE ROC SDN. BHD. | Malaysia | ||||
| Linde RSS LLC | Delaware | ||||
| Linde Russia UK Limited | England & Wales | ||||
| LINDE SAÚDE, LDA | Portugal | ||||
| Linde Schweißtechnik GmbH | Germany | ||||
| Linde Services Canada Inc. | Canada | ||||
| Linde Services Inc. | Texas | ||||
| LINDE SOUTH AFRICA (PTY) LTD | South Africa | ||||
| Linde South Asia Services Private Limited | India | ||||
| LINDE SPECIAL PROJECTS LLC | Delaware | ||||
| LINDE SSC S. DE R.L. DE C.V. | Mexico | ||||
| Linde Sverige AB | Sweden | ||||
| LINDE UK HOLDINGS LIMITED | England | ||||
| LINDE UK PRIVATE MEDICAL TRUSTEES LIMITED | England | ||||
| Linde Uruguay Limitada | Uruguay | ||||
| Linde Vietnam Limited Company | Vietnam | ||||
| Linde Wanhua (Fujian) Gases Co., Ltd. | China | ||||
| Linde Wanhua (Ningbo) Gases Co., Ltd. | China | ||||
| Linde-Navoiy LLC | Uzbekistan | ||||
| LINDE-SINOCHEM (QUANZHOU) GASES CO., LTD | China | ||||
| Liquid Carbonic Corporation | Delaware | ||||
| Liquid Carbonic del Paraguay S.A. | Paraguay | ||||
| Líquido Carbónico Colombiana S.A.S. | Colombia | ||||
| LPM, S.A. de C.V. | Mexico | ||||
| LUCK STREAM Co., Ltd. | Taiwan (Province of China) | ||||
| Madison Gas LLC | Delaware | ||||
| Maple Respiratory I.P.S. S.A.S. | Colombia | ||||
| Mastercrio Transportes Ltda. | Brazil | ||||
| Maverick Healthcare Group L.L.C. | Arizona | ||||
| Maverick Healthcare Holdings II, Inc. | Delaware | ||||
| mdINR, LLC | Delaware | ||||
| Medical Gases S. R. L. | Argentina | ||||
| MEDIMATICS LLC | Delaware | ||||
| MEDISHIELD | England | ||||
| MEDISPEED | England | ||||
| Michigan Industrial Gases Inc. | Michigan | ||||
| Middlesex Gases & Technologies, Inc. | Massachusetts | ||||
| MidSouth Distribution, Inc. | Texas | ||||
| MIG Production Company Limited | Thailand | ||||
| Miller Industrial Gases, LLC | Michigan | ||||
| Miller Welding Supply Company | Michigan | ||||
| MRB ACQUISITION CORP. | Florida | ||||
| MTA GmbH Medizin-Technischer-Anlagenbau | Germany | ||||
| Murray Hill LLC | Delaware | ||||
| Naamloze Vennootschap Linde Gas Benelux | Netherlands | ||||
| NAMOX Namibia (PTY) LIMITED | Namibia | ||||
| Nanjing Linde Nanlian Industrial Gas Co., Ltd. | China | ||||
| NASIONALE SWEISWARE (PTY) LTD | South Africa | ||||
| NEW SINO GASES COMPANY LIMITED | Hong Kong | ||||
| nexAir Carbonic, LLC | Mississippi | ||||
| nexAir Production, LLC | Tennessee | ||||
| nexAir Southeast, LLC | Delaware | ||||
| nexAir, LLC | Tennessee | ||||
| NICOWELD (PTY) LIMITED | South Africa | ||||
| Nitropet, S.A. de C.V. | Mexico | ||||
| NORLIC AB | Sweden | ||||
| Northeast Pennsylvania Alliance, LLC | Pennsylvania | ||||
| NoxBox Ltd | England | ||||
| NuCO2 Inc. | Delaware | ||||
| NuCO2 LLC | Delaware | ||||
| NuCO2 Management LLC | Delaware | ||||
| NuCO2 Supply LLC | Delaware | ||||
| OCAP CO2 B.V. | Netherlands | ||||
| OPTIGEN, INC. | Florida | ||||
| Option One Home Medical Equipment, Inc. | California | ||||
| Oxigenos de Colombia Ltda. | Colombia | ||||
| Oy Linde Gas Ab | Finland | ||||
| P.T. Gresik Gases Indonesia | Indonesia | ||||
| P.T. Gresik Power Indonesia | Indonesia | ||||
| PACIFIC ENGINEERING SUPPLIES PTY LIMITED | New South Wales | ||||
| Park Infusion Care GP, LLC | Delaware | ||||
| Park Infusion Care, LP | Texas | ||||
| Patient Support Services, Inc. | Texas | ||||
| PG Technologies Pte Ltd. | Singapore | ||||
| PG Technologies, LLC | Delaware | ||||
| Piedmont Medical Equipment | South Carolina | ||||
| Praxair (China) Investment Co., Ltd. | China | ||||
| Praxair (Thailand) Company Limited | Thailand | ||||
| Praxair Argentina S.R.L. | Argentina | ||||
| Praxair Asia, Inc. | Delaware | ||||
| Praxair Bahrain BSC C | Bahrain | ||||
| Praxair Business Solutions and Supplies Private Limited | India | ||||
| Praxair Chile Ltda. | Chile | ||||
| Praxair Colonia Limitada | Uruguay | ||||
| Praxair Costa Rica, S.A. | Costa Rica | ||||
| Praxair do Brasil Ltda. | Brazil | ||||
| Praxair Euroholding B.V. | Netherlands | ||||
| Praxair Fray Bentos S.C.A. | Uruguay | ||||
| Praxair Gases Industriales Ltda. | Colombia | ||||
| Praxair Holding Latinoamerica SARL | Luxembourg | ||||
| Praxair Holdings International, Inc. | Delaware | ||||
| Praxair Huayi (Chongqing) Industrial Gases Co., Ltd. | China | ||||
| Praxair Hydrogen Supply, Inc. | Delaware | ||||
| Praxair India Private Limited | India | ||||
| Praxair International Finance Unlimited Company | Ireland | ||||
| Praxair Investments B.V. | Netherlands | ||||
| Praxair Latin America Holdings LLC | Delaware | ||||
| Praxair Mexico, S. de R.L. de C.V. | Mexico | ||||
| Praxair Offshore Services Limited | England | ||||
| Praxair Pacific Ltd. | Mauritius | ||||
| Praxair Panama S.A. | Panama | ||||
| Praxair Partnership | Delaware | ||||
| Praxair Plainfield, Inc. | Delaware | ||||
| Praxair Puerto Rico LLC | Delaware | ||||
| Praxair Republica Dominicana, SRL | Dominican Republic | ||||
| Praxair S. T. Technology, Inc. | Delaware | ||||
| Praxair Ship II AS | Norway | ||||
| Praxair Surface Technologies Montreal L.P. | New Brunswick | ||||
| Praxair Switzerland GmbH | Switzerland | ||||
| Praxair Technology, Inc. | Delaware | ||||
| Preferred Acquisitions Corp. | Delaware | ||||
| Preferred Homecare Infusion, L.L.C. | Arizona | ||||
| PREMIER MEDICAL CORPORATION | Colorado | ||||
| PRIESTLEY COMPANY LIMITED | Bermuda | ||||
| Private Joint Stock Company "Linde Gas Ukraine" | Ukraine | ||||
| Production Praxair Canada Inc. | Canada | ||||
| PS Chem Co., Ltd. | Korea (the Republic of) | ||||
| PSG Co., Ltd. | Korea (the Republic of) | ||||
| PT. LINDE INDONESIA | Indonesia | ||||
| PULMOREHAB LLC | Delaware | ||||
| RAYONG ACETYLENE LIMITED | Thailand | ||||
| Raytel Cardiac Services, Inc. | Delaware | ||||
| RCS MANAGEMENT CORPORATION | Delaware | ||||
| RCS MANAGEMENT HOLDING COMPANY | Delaware | ||||
| RDC GASES & WELDING (DRL) LIMITED | Congo, The Democratic Republic of the | ||||
| Remote Connected Care LLC | Delaware | ||||
| REPTILE INVESTMENT NINE (PTY) LIMITED | Namibia | ||||
| REPTILE INVESTMENT TEN (PTY) LIMITED | Namibia | ||||
| Rivet Energy Fleetco Pty Ltd | Victoria | ||||
| ROCK INDUSTRIAL & WELDING SUPPLIES LIMITED | England | ||||
| ROYAL SOUTHMEADOWS, INC. | Philippines | ||||
| Ruppco, Inc. | Delaware | ||||
| RYVAL GAS LIMITED | England | ||||
| Saudi Industrial Gas Company | Saudi Arabia | ||||
| SELECT LOGISTICS AND TRANSPORT PTY LTD | New South Wales | ||||
| SELOX, INC | Tennessee | ||||
| SERMATEC VIETNAM COMPANY LIMITED | Vietnam | ||||
| Sermatech International Canada Corp. | Delaware | ||||
| Sermatech International Canada GP LLC | Delaware | ||||
| SERVICIOS DE OPERACIONES DE NITRÓGENO, S.A. DE C.V. | Mexico | ||||
| Shanghai Baoshan Linde Gas Co., Ltd. | China | ||||
| Shanghai Jinshan Linde Gas Product Co., Ltd. | China | ||||
| Shanghai Linde Yidian Gas Co., Ltd. | China | ||||
| Shared Care of West Branch, LLC | Michigan | ||||
| SKTY (Thailand) Limited | Thailand | ||||
| Sleepcair, Inc. | Kansas | ||||
| SMS HOLDINGS (DELAWARE), INC. | Delaware | ||||
| SMS HOLDINGS, INC. | Delaware | ||||
| Solucoes em Gases Industriais Ltda. | Brazil | ||||
| SOUTH PACIFIC WELDING GROUP PTY LIMITED | New South Wales | ||||
| South Park Welding Supplies, L.L.C. | Michigan | ||||
| SPECIALIZED MEDICAL SERVICES, INC. | Wisconsin | ||||
| Spectra Gases (Shanghai) Trading Co., LTD. | China | ||||
| Spectra Gases Limited | England | ||||
| STORESHIELD LIMITED | England | ||||
| Sure/Arc Welding Supply (1977) Ltd. | Canada | ||||
| Suzhou Industrial Park Linde Gas Co., Ltd. | China | ||||
| Svenska Aktiebolaget Gasaccumulator | Sweden | ||||
| Svets Gas Aktiebolag | Sweden | ||||
| T.I.G. TRADING LIMITED | Thailand | ||||
| Technical Gas S.A. | Venezuela | ||||
| Thai Carbonic Company, Ltd. | Thailand | ||||
| The BOC Group B.V. | Netherlands | ||||
| THE BOC GROUP LIMITED | England | ||||
| THE BRITISH OXYGEN COMPANY LIMITED | England | ||||
| The National Medical Rentals, Inc. | Arkansas | ||||
| TIAMONT PTY LIMITED | New South Wales | ||||
| TK-Teollisuuskaasut Oy | Finland | ||||
| TOO Linde Gaz Kazakhstan | Kazakhstan | ||||
| TRANSHIELD | England | ||||
| UNIGAS JOINT VENTURE PARTNERSHIP | Victoria | ||||
| Vision Energy Group LLC | Oklahoma | ||||
| Wasserstoffkonsortium Alstom-Linde Bremervörde GbR | Germany | ||||
| WELDER EQUIPMENT SERVICES LIMITED | England | ||||
| WELDING PRODUCTS HOLDINGS LIMITED | England | ||||
| WELSCO, Inc. | Arkansas | ||||
| Westair Cryogenics Company | Delaware | ||||
| Westair Gas and Equipment, L.P. | Texas | ||||
| White Martins & White Martins - Comércio e Serviços S.à.r.l. | Luxembourg | ||||
| White Martins Gases Industriais do Nordeste Limitada | Brazil | ||||
| White Martins Gases Industriais do Norte Limitada | Brazil | ||||
| White Martins Gases Industriais Ltda. | Brazil | ||||
| White Martins Participações Ltda. | Brazil | ||||
| White Martins Pecem Gases Industriais Ltda. | Brazil | ||||
| White Martins Steel Gases Industriais Ltda. | Brazil | ||||
| WM Transporte de Gases Ltda. | Brazil | ||||
| Yantai Feiyuan Specialty Gases Co., Ltd. | China | ||||
| Yantai Wanhua Huasheng Gases Co., Ltd. | China | ||||
| Yateem Oxygen W.L.L. | Bahrain | ||||
| Zamalight Holdco LLC | Delaware | ||||
| February 25, 2026 | By:/s/ Sanjiv Lamba | ||||||||||
| Sanjiv Lamba | |||||||||||
| Chairman and Chief Executive Officer | |||||||||||
| February 25, 2026 | By: /s/ Matthew J. White | ||||||||||
| Matthew J. White | |||||||||||
| Chief Financial Officer | |||||||||||
| February 25, 2026 | By:/s/ Sanjiv Lamba | ||||||||||
| Sanjiv Lamba | |||||||||||
| Chairman and Chief Executive Officer | |||||||||||
| February 25, 2026 | By: /s/ Matthew J. White | ||||||||||
| Matthew J. White | |||||||||||
| Chief Financial Officer | |||||||||||